 |
| PDB ID: 5zvm Macromolecule: SPIKE GLYCOPROTEIN Source Organism: SARSr-CoV Gene names: S UniProt ID: P59594 |
SIMILAR PATTERN OF AMINO ACIDS MAPPED TO PDBID '5zvm'
1) User may click on the DrReposER ID (the first column) to get information on the binding sites and drug molecule.2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.| DrReposER ID / Desc. | Drug | Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
|---|---|---|---|---|---|---|---|---|---|
 Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BDM_A_TMIA502_1 (CYTOCHROME P450 2B4) | Bifonazole | 6 / 12 | LEU a 32LEU A 920ILE A 916ILE C 916LEU B 920THR B 921 | 1.48A | 6.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5U4S_A_BEZA301_0 (PUTATIVE SHORT CHAINDEHYDROGENASE) | Benzoic Acid | 4 / 7 | SER C 919ILE C 916LEU B 920LEU b 25 | 1.46A | 14.78 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R3A_B_RBFB402_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) | Riboflavin | 5 / 10 | ILE B 955ASN C 951VAL B 945LEU B 948PHE A 952 | 1.74A | 13.03 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PD4_C_AOQC4003_1 (CYTOCHROME B) | Atovaquone | 5 / 12 | VAL A 897LEU C 898TYR C 899LEU c 39ILE B 905 | 1.46A | 12.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UG2_A_IREA1_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | Gefitinib | 5 / 12 | LEU A 930ALA A 926LEU A 920LEU c 18GLY C 928 | 1.42A | 14.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VKQ_A_PCFA1803_0 (NO MECHANORECEPTORPOTENTIAL C ISOFORML) | Colfosceril palmitate | 5 / 10 | TYR b 20ILE C 916ILE A 916LEU a 32ILE b 29 | 1.78A | 2.48 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NDN_A_SAMA407_1 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) | S-Adenosylmethionine | 4 / 8 | ALA A 906GLN A 908ASP c 38ILE c 37 | 1.20A | 11.99 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MXW_A_ML1A218_1 (CLASS 10 PLANTPATHOGENESIS-RELATEDPROTEIN) | Melatonin | 5 / 11 | LEU A 941VAL A 945ILE c 11LEU c 8VAL B 945 | 1.45A | 18.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AIA_A_SAMA206_0 (UPF0217 PROTEINMJ1640) | S-Adenosylmethionine | 4 / 6 | LEU C 948GLY C 953LEU B 948SER B 949 | 1.33A | 16.75 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EE2_A_CHDA1150_0 (ALCOHOLDEHYDROGENASE) | Cholic Acid | 5 / 11 | SER c 35LEU c 32LEU a 32SER A 919ILE A 913 | 1.56A | 7.51 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EJG_B_NCTB501_1 (CYTOCHROME P450 2A13) | Nicotine | 5 / 8 | PHE C 952ASN A 951PHE A 952LEU B 948LEU C 948 | 1.73A | 11.08 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | Fluvoxamine | 5 / 9 | ILE B 955SER C 950PHE B 952SER B 957GLY B 953 | 1.50A | 9.98 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XT7_A_TOPA302_1 (RV2671) | Trimethoprim | 5 / 11 | THR C 925SER C 924GLY C 928GLU c 26THR A 922 | 1.50A | 13.78 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K4Y_E_ACTE503_0 (RNA-DEPENDENT RNAPOLYMERASE) | Acetic acid | 4 / 4 | LYS a 24LEU a 25GLU a 21LEU A 927 | 1.80A | 9.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3H52_D_486D2_1 (GLUCOCORTICOIDRECEPTOR) | Mifepristone | 5 / 12 | GLN A 931VAL A 933LEU A 927MET b 22LEU C 927 | 1.44A | 18.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQN_B_NDRB2001_0 (PROGESTERONERECEPTOR) | Norethisterone | 5 / 12 | LEU a 16LEU A 930LEU c 16GLN C 931LEU b 18 | 1.51A | 12.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MJ8_A_SPMA202_1 (SPERMIDINEN1-ACETYLTRANSFERASE) | Spermine | 4 / 8 | GLU c 34GLU c 27GLN A 915ILE A 913 | 1.38A | 15.60 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WBO_A_ANWA601_0 (RHODOPSIN KINASE) | Amlexanox | 5 / 7 | LEU C 941ILE c 11LEU A 948VAL a 13ALA B 940 | 1.27A | 10.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M50_E_TA1E502_1 (TUBULIN BETA-2BCHAIN) | Paclitaxel | 5 / 12 | ASP b 17GLU b 19LEU A 927THR A 923LEU b 25 | 1.59A | 7.21 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OXW_B_017B200_2 (HIV-1 PROTEASE) | Darunavir | 5 / 10 | LEU B 966VAL B 958ILE B 955VAL A 958ILE B 962 | 1.47A | 19.81 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FAL_C_REAC501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) | Tretinoin | 5 / 10 | ILE B 916GLN C 915LEU B 920ALA b 28ILE A 913 | 1.53A | 15.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VMY_A_FFOA505_1 (SERINEHYDROXYMETHYLTRANSFERASE) | Levoleucovorin | 5 / 12 | LEU a 18GLY A 928SER A 924ALA A 926GLY B 928 | 1.36A | 8.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_D_9F2D400_1 (BETA-LACTAMASE) | Ceftriaxone | 5 / 12 | SER B 924THR C 922THR C 923GLY B 928ASP B 932 | 1.56A | 15.18 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G95_B_RTZB708_1 (ENVELOPEGLYCOPROTEIN) | Thioridazine | 5 / 8 | LEU C 941LEU A 944LEU c 8LEU b 8ILE b 11 | 0.91A | 13.5118.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FL9_D_TOPD200_1 (DIHYDROFOLATEREDUCTASE (DHFR)) | Trimethoprim | 5 / 9 | ALA a 28LEU a 32GLU B 918ILE C 916LEU b 32 | 1.77A | 12.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ABZ_A_T1CA1209_1 (TETRACYCLINEREPRESSOR CLASS D) | Tigecycline | 5 / 12 | ASN A 951GLN c 10GLN A 947LEU C 941SER C 949 | 1.72A | 18.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N4F_A_ASRA140_0 (LYSOZYME C) | Arsanilic acid | 3 / 3 | ASN a 12ALA B 940ASN B 937 | 0.99A | 13.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CJT_K_SAMK302_0 (RIBOSOMAL PROTEINL11METHYLTRANSFERASE) | S-Adenosylmethionine | 5 / 12 | SER C 950ILE c 11ASP c 9LEU C 944LEU C 941 | 1.42A | 15.28 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q1E_D_T44D328_1 (5-HYDROXYISOURATEHYDROLASE) | Levothyroxine | 5 / 9 | LEU B 927THR A 923LEU c 25LEU C 920SER C 919 | 1.41A | 20.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZJL_A_ERYA1101_0 (MULTIDRUG EFFLUXPUMP SUBUNIT ACRB) | Erythromycin | 5 / 12 | SER C 919SER B 914PHE B 909GLU B 918THR A 923 | 1.68A | 6.75 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MVM_A_PFLA510_1 (PROTON-GATED IONCHANNEL) | Propofol | 5 / 9 | ILE A 913ALA A 912ILE A 916ILE B 913ALA B 912 | 1.41A | 14.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZGF_A_BEZA210_0 (UNCHARACTERIZEDPROTEIN) | Benzoic Acid | 4 / 4 | VAL c 13ALA C 938ASN C 937GLN C 939 | 1.73A | 17.36 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B6H_A_MXDA551_1 (PROSTACYCLINSYNTHASE) | Minoxidil | 5 / 6 | ALA A 938LEU A 941ALA B 940THR B 943ASN B 942 | 1.69A | 10.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QZF_A_FOLA605_0 (BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) | Folic Acid | 5 / 12 | ALA A 926LEU C 927LEU c 25LEU B 920THR A 925 | 1.50A | 9.74 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CD2_A_FOLA207_0 (DIHYDROFOLATEREDUCTASE) | Folic Acid | 5 / 12 | ALA C 954ILE B 955PHE B 952PHE A 952LEU B 948 | 1.63A | 19.76 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JIN_A_KTNA801_1 (CYTOCHROME P450107A1) | Ketoconazole | 5 / 11 | SER A 950PHE A 952LEU A 941ALA A 940LEU C 948 | 1.45A | 12.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ITZ_B_LOCB502_1 (TUBULIN BETA-2BCHAIN) | Colchicine | 5 / 12 | LEU A 948LEU A 941ASN C 942ALA C 940ILE b 11 | 1.48A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O1Z_A_MXMA807_1 (PROSTAGLANDIN G/HSYNTHASE 1) | Meloxicam | 5 / 12 | LEU C 930GLY B 928ALA B 926LEU b 25LEU B 920 | 1.26A | 8.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DF7_A_MTXA501_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | ILE C 913ILE A 913GLN A 915LEU C 920ILE C 916 | 1.36A | 21.48 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1H9Z_A_RWFA3001_1 (SERUM ALBUMIN) | Warfarin | 5 / 11 | ALA A 940LEU C 941LEU A 941LEU B 944ALA B 938 | 1.54A | 9.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_B_9F2B400_1 (BETA-LACTAMASE) | Ceftriaxone | 5 / 12 | SER B 924THR C 922THR C 923GLY B 928ASP B 932 | 1.52A | 15.18 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4F3T_A_IPHA902_0 (PROTEIN ARGONAUTE-2) | Phenol | 4 / 6 | LEU B 930LYS B 929LEU a 18GLU a 21 | 1.55A | 8.42 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R38_B_RBFB201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) | Riboflavin | 5 / 12 | ALA b 28ALA B 912ILE B 916LEU c 32GLN C 917 | 1.54A | 20.37 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X23_A_LSNA502_1 (CYTOCHROME P450 2C9) | Losartan | 5 / 12 | VAL C 958ASN A 951GLY C 953ALA C 954LEU B 959 | 1.32A | 10.86 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JB2_A_SAMA1101_1 (STRUCTURAL PROTEINVP3) | S-Adenosylmethionine | 3 / 3 | GLU a 19ASP a 17ASP A 932 | 1.51A | 3.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3L2V_A_RLTA397_1 (INTEGRASE) | Raltegravir | 4 / 7 | GLN A 895TYR A 899GLN B 902GLU B 900 | 1.69A | 14.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R38_C_RBFC201_2 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) | Riboflavin | 5 / 9 | THR B 923GLU b 26LEU C 920LEU b 32ILE C 916 | 1.61A | 20.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1U72_A_MTXA188_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | ALA C 912LEU b 32GLN B 908SER B 919LEU a 32 | 1.51A | 17.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AXA_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) | Adenosine | 4 / 5 | GLU B 918THR B 922THR A 922LEU C 920 | 1.74A | 9.60 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I89_A_1FLA201_1 (TRANSTHYRETIN) | Diflunisal | 5 / 6 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.78A | 23.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y01_A_Y00A601_1 (BETA-1 ADRENERGICRECEPTOR) | Dobutamine | 5 / 12 | VAL a 13PHE c 15ASN C 935VAL A 934ASN A 937 | 1.67A | 11.30 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GWR_A_ESTA600_1 (OESTROGEN RECEPTOR) | Estradiol | 5 / 10 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.53A | 10.74 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IA4_D_MTXD164_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | ILE b 29ALA b 28LEU C 920ILE A 916LEU A 920 | 1.73A | 16.81 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG2_C_CHDC271_0 (CYTOCHROME C OXIDASESUBUNIT 3) | Cholic Acid | 4 / 7 | LEU B 948GLN B 947LEU C 948PHE C 952 | 1.28A | 18.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AK3_A_P2EA1201_0 (PROSTAGLANDIN E2RECEPTOR EP3SUBTYPE,SOLUBLECYTOCHROME B562) | Dinoprostone | 5 / 12 | GLN C 939THR C 943VAL C 945LEU B 944GLN C 936 | 1.69A | 11.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UA5_B_06XB501_1 (CYTOCHROME P450 2B6) | Amlodipine | 4 / 7 | ILE B 913ILE A 916GLU C 918LEU B 920 | 1.15A | 10.63 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OZV_B_ECNB411_1 (FLAVOHEMOGLOBIN) | Econazole | 5 / 9 | ILE c 29ILE C 916ALA b 28LEU c 25ALA c 28 | 1.37A | 9.54 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KTT_A_SAMA405_1 (S-ADENOSYLMETHIONINESYNTHASE ISOFORMTYPE-2) | S-Adenosylmethionine | 4 / 8 | ALA A 906GLN A 908ASP c 38ILE c 37 | 1.30A | 11.31 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DTL_A_BEPA204_1 (CARDIAC TROPONIN C) | Bepridil | 5 / 11 | LEU B 941LEU b 8VAL a 13LEU c 8LEU C 948 | 1.59A | 21.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3R9C_A_ECLA451_1 (CYTOCHROME P450164A2) | Econazole | 5 / 10 | LEU b 8LEU C 948LEU B 941ILE b 11ALA C 940 | 1.23A | 8.06 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UIV_H_308H1008_1 (SERUM ALBUMIN) | Amantadine | 5 / 6 | LEU A 959LEU B 959ILE C 955SER B 957ALA B 954 | 1.45A | 9.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIW_B_LOCB504_2 (TUBULIN BETA CHAIN) | Colchicine | 5 / 12 | LEU A 920LEU C 920ALA A 912ALA c 28ILE A 913 | 1.30A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1U18_B_HSMB402_1 (NITROPHORIN 1) | Histamine | 4 / 5 | GLU b 19THR B 923LEU B 927LEU b 25 | 1.48A | 17.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FAL_A_REAA501_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) | Tretinoin | 5 / 10 | ILE B 916ALA C 912GLN C 915ALA b 28ILE A 913 | 1.60A | 15.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4F4D_B_CHDB505_0 (FERROCHELATASE,MITOCHONDRIAL) | Cholic Acid | 5 / 12 | LEU B 930LEU B 927LEU b 25SER C 919THR C 921 | 1.12A | 14.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IK6_B_LURB201_1 (TRANSTHYRETIN) | Lumiracoxib | 5 / 8 | LYS C 929LEU b 16THR C 925ALA C 926LEU B 930 | 1.79A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W9S_C_TOPC1160_1 (DIHYDROFOLATEREDUCTASE TYPE 1FROM TN4003) | Trimethoprim | 5 / 10 | ALA b 28LEU B 920ILE B 913SER A 919ILE A 916 | 1.47A | 18.42 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GWR_A_ESTA600_1 (OESTROGEN RECEPTOR) | Estradiol | 5 / 10 | LEU B 927ALA B 926LEU A 927LEU C 927LEU a 16 | 1.49A | 16.39 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HJH_A_NCAA900_0 (NAD-DEPENDENTHISTONE DEACETYLASESIR2) | Nicotinamide | 4 / 5 | ILE c 37PHE B 909PHE A 909ILE C 913 | 1.46A | 10.10 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JW1_B_CELB602_1 (PROSTAGLANDIN G/HSYNTHASE 2) | Celecoxib | 5 / 12 | LEU a 25ALA b 28GLY B 928ALA B 926LEU a 18 | 1.50A | 6.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YJA_B_ESTB1550_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 12 | ALA B 926MET a 22LEU a 25GLY A 928LEU A 930 | 1.40A | 15.94 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6E43_A_BEZA502_0 (INDOLEAMINE2,3-DIOXYGENASE 1) | Benzoic Acid | 4 / 6 | PHE B 952VAL C 945LEU B 944LEU B 948 | 1.50A | 10.91 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZBF_A_VGHA3000_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ROS) | Crizotinib | 5 / 12 | LEU b 25ALA C 926LEU A 930LEU C 930LEU A 927 | 1.10A | 11.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B0I_B_TA1B502_1 (TUBULIN BETA CHAIN) | Paclitaxel | 5 / 12 | VAL c 13LEU B 944LEU A 941ALA A 940LEU c 8 | 1.44A | 8.21 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NYR_B_SVRB401_1 (NAD-DEPENDENTDEACETYLASESIRTUIN-5) | Suramin | 5 / 12 | ALA c 28ALA C 912PHE C 909ILE A 916LEU b 25 | 1.39A | 10.16 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | Bicalutamide | 5 / 12 | LEU c 25ALA A 926THR A 925GLU A 918THR A 921 | 1.56A | 8.44 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SN0_C_T44C601_1 (TRANSTHYRETIN) | Levothyroxine | 5 / 9 | LEU B 930ALA B 926LEU B 927LEU a 25ALA A 926 | 1.71A | 19.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E7C_A_HLTA4007_1 (SERUM ALBUMIN) | Halothane | 4 / 8 | LEU B 927ASP b 17LEU b 16LEU b 18 | 1.34A | 9.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N13_D_AG2D7015_1 (PYRUVOYL-DEPENDENTARGININEDECARBOXYLASE ALPHACHAINPYRUVOYL-DEPENDENTARGININEDECARBOXYLASE BETACHAIN) | Agmatine | 4 / 7 | LEU c 16LEU C 930LEU A 927GLY A 928 | 1.40A | 18.4517.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OR0_B_NPSB602_1 (SERUM ALBUMIN) | Naproxen | 5 / 9 | ALA A 940ALA A 938LEU A 941LEU A 944VAL A 945 | 1.66A | 8.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZJI_A_PQNA844_1 (PHOTOSYSTEM I P700CHLOROPHYLL AAPOPROTEIN A1PHOTOSYSTEM IREACTION CENTERSUBUNIT IX) | Phylloquinone | 5 / 10 | PHE B 952SER B 956GLY B 953LEU B 948PHE c 15 | 1.73A | 7.3720.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1CQP_B_803B311_1 (ANTIGEN CD11A (P180)) | Lovastatin | 4 / 7 | VAL C 958LEU A 959VAL A 958LEU B 966 | 1.22A | 19.57 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DFR_A_MTXA164_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | ALA B 926LEU A 927LEU c 25ALA C 926THR B 925 | 1.41A | 17.28 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TYR_A_9CRA131_1 (TRANSTHYRETIN) | Alitretinoin | 5 / 6 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.66A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OU6_B_SAMB300_1 (SAM-DEPENDENTMETHYLTRANSFERASE) | S-Adenosylmethionine | 3 / 3 | TYR b 20ASP b 17ASP B 932 | 1.66A | 11.76 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I89_B_1FLB201_1 (TRANSTHYRETIN) | Diflunisal | 4 / 4 | LYS C 929ALA C 926SER B 924THR C 923 | 1.50A | 23.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1J3J_A_CP6A609_1 (BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) | Pyrimethamine | 5 / 10 | ILE A 905ASN A 910SER A 914ILE A 913ILE a 37 | 1.78A | 15.21 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3R9V_B_DXCB1_0 (INVASIN IPAD) | Deoxycholic Acid | 4 / 7 | ILE b 29LEU B 920LEU A 920SER a 35 | 1.30A | 12.66 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G9I_B_CXXB707_1 (ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN) | Clomipramine | 5 / 7 | ILE b 11LEU B 941VAL A 945LEU C 948LEU B 944 | 1.62A | 9.2310.49 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q1E_C_T44C128_1 (5-HYDROXYISOURATEHYDROLASE) | Levothyroxine | 4 / 6 | LEU b 25LEU B 920LEU a 25LEU A 920 | 1.25A | 15.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XN5_A_FUNA1356_1 (THYROXINE-BINDINGGLOBULIN) | Furosemide | 5 / 11 | LEU A 927LEU A 930LEU C 930LYS C 929LEU c 18 | 1.41A | 14.02 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GS4_A_ESTA603_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 12 | ALA B 926MET a 22LEU a 25GLY A 928LEU A 930 | 1.44A | 15.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BL9_A_CP6A1240_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) | Pyrimethamine | 5 / 12 | ALA b 28LEU B 920SER A 919ILE A 916ILE C 913 | 1.47A | 18.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FE2_A_LAXA700_2 (PROSTAGLANDINENDOPEROXIDE HSYNTHASE-1) | Dihomo-gamma-linolenic acid | 5 / 12 | PHE A 952GLY A 953ALA A 954SER A 956LEU A 959 | 1.52A | 8.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B0L_B_TA1B502_1 (TUBULIN BETA CHAIN) | Paclitaxel | 5 / 12 | ASP b 17LEU c 25THR A 923GLY B 928LEU B 930 | 1.38A | 8.21 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V0V_A_8QPA612_1 (SERUM ALBUMIN) | Etodolac | 5 / 12 | LEU A 927LEU A 930LEU c 18ALA C 926GLU b 21 | 1.53A | 8.46 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLS_B_ESTB600_1 (ESTROGEN RECEPTORBETA) | Estradiol | 5 / 12 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.50A | 9.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IK7_B_IMNB201_1 (TRANSTHYRETIN) | Indomethacin | 5 / 8 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.78A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5T8S_B_SAMB402_0 (S-ADENOSYLMETHIONINESYNTHASE) | S-Adenosylmethionine | 4 / 8 | ALA A 906GLN A 908ASP c 38ILE c 37 | 1.20A | 11.84 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MSS_B_STIB1_1 (TYROSINE-PROTEINKINASE ABL1) | Imatinib | 5 / 12 | LEU A 930ALA A 926ILE C 916THR A 923GLY C 928 | 1.30A | 14.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3R9T_A_BEZA264_0 (ECHA1_1) | Benzoic Acid | 4 / 8 | ALA A 912ILE A 916LEU c 32ALA C 912 | 0.85A | 17.21 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GH8_A_MTXA201_2 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 3 / 3 | LYS a 31ILE A 913THR A 921 | 1.17A | 11.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLS_A_ESTA600_1 (ESTROGEN RECEPTORBETA) | Estradiol | 5 / 12 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.50A | 9.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OZK_B_T44B128_1 (TRANSTHYRETIN) | Levothyroxine | 5 / 7 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.78A | 21.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VEU_B_RITB602_1 (CYTOCHROME P450 3A5) | Ritonavir | 5 / 12 | SER A 956PHE B 952PHE C 952ILE B 955ALA B 954 | 1.38A | 11.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MA8_C_Z80C301_1 (MAJOR PRION PROTEIN) | Chlorpromazine | 4 / 5 | LEU A 920ILE B 916LYS B 911GLN B 915 | 1.56A | 17.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GC9_A_SAMA401_0 (DIMETHYLADENOSINETRANSFERASE 1,MITOCHONDRIAL) | S-Adenosylmethionine | 5 / 12 | GLY B 953ILE B 955ASN B 951LEU B 948VAL B 945 | 1.40A | 14.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FRB_X_TOPX300_1 (DIHYDROFOLATEREDUCTASE) | Trimethoprim | 5 / 11 | LEU c 25ALA C 926LEU B 927LEU b 25THR C 925 | 1.47A | 13.16 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1Y_D_LOCD502_2 (TUBULIN BETA CHAIN) | Colchicine | 5 / 12 | LEU c 18LEU C 930LEU A 927THR B 922ALA C 926 | 1.39A | 8.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ONI_D_BEZD507_0 (14.5 KDATRANSLATIONALINHIBITOR PROTEIN) | Benzoic Acid | 4 / 7 | PHE C 909ALA A 912ILE A 905ILE a 37 | 1.11A | 21.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TLM_A_MILA128_1 (TRANSTHYRETIN) | Milrinone | 3 / 3 | LEU a 25LEU A 920SER A 919 | 0.77A | 22.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FUK_B_SNPB1236_1 (MROUPO) | Propranolol | 5 / 8 | ILE B 913LEU b 32ALA C 912ILE C 913PHE B 909 | 1.43A | 22.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2J0D_A_ERYA1498_0 (CYTOCHROME P450 3A4) | Erythromycin | 5 / 12 | ILE B 905ILE C 905PHE C 909ALA C 906GLU A 900 | 1.37A | 11.78 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y7Z_A_IREA401_0 (CYCLIN-G-ASSOCIATEDKINASE) | Gefitinib | 5 / 12 | LEU A 944VAL C 945LYS C 946LEU B 948LEU B 941 | 1.51A | 15.44 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YAJ_D_BEZD2385_0 (CES1 PROTEIN) | Benzoic Acid | 4 / 5 | LEU B 944SER A 949LEU c 8LEU A 941 | 1.26A | 9.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q83_A_ADNA1_1 (YTAA PROTEIN) | Adenosine | 4 / 7 | ILE a 29ILE C 916LEU B 920ILE B 916 | 1.34A | 11.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LN1_C_CELC682_2 (PROSTAGLANDIN G/HSYNTHASE 2) | Celecoxib | 4 / 7 | SER C 950LEU A 948ILE C 955PHE C 952 | 1.30A | 8.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DEU_A_SALA305_1 (TRANSCRIPTIONALREGULATOR SLYA) | Salicylic acid | 4 / 7 | THR A 923THR C 923SER B 919THR B 923 | 1.18A | 21.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q1E_D_T44D328_1 (5-HYDROXYISOURATEHYDROLASE) | Levothyroxine | 5 / 9 | LEU a 25LEU A 920THR C 923LEU b 25LEU B 920 | 1.28A | 15.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MS9_B_STIB1_1 (TYROSINE-PROTEINKINASE ABL1) | Imatinib | 5 / 12 | LEU B 930ALA B 926ILE A 916THR B 923GLY A 928 | 1.28A | 14.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IE9_A_VDXA500_1 (VITAMIN D3 RECEPTOR) | Calcitriol | 5 / 12 | LEU b 25LEU B 920SER B 919SER A 919LEU C 927 | 1.46A | 12.55 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EII_A_RTLA135_0 (CELLULARRETINOL-BINDINGPROTEIN II) | Vitamin A | 5 / 12 | ALA A 912THR C 922LEU b 25LEU b 32LEU A 920 | 1.60A | 23.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3D2T_A_1FLA502_1 (TRANSTHYRETIN) | Diflunisal | 5 / 7 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.76A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N09_A_ADNA401_2 (ADENOSINE KINASE) | Adenosine | 4 / 4 | LEU b 25SER B 919LEU C 920LEU B 927 | 1.29A | 9.21 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XP3_A_DX4A401_0 (MITOGEN-ACTIVATEDPROTEIN KINASE 1) | Tioguanine | 4 / 6 | ALA C 926LYS C 929LEU B 927MET b 22 | 1.69A | 15.20 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CCQ_A_ACTA1317_0 (THIOREDOXINREDUCTASE) | Acetic acid | 3 / 3 | LEU c 25GLU c 21SER A 919 | 1.50A | 13.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DAU_A_MTXA201_2 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 3 / 3 | SER a 35ILE a 29THR B 923 | 1.02A | 18.02 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GPG_A_RAPA301_1 (PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP3) | Sirolimus | 5 / 11 | LEU C 920LYS c 31ILE C 913ALA B 912ILE B 913 | 1.56A | 24.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B0C_D_TA1D502_1 (TUBULIN BETA CHAIN) | Paclitaxel | 5 / 12 | GLU a 21LEU c 16LEU c 18GLY B 928LEU B 927 | 1.31A | 8.21 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTI_B_CCSB47_0 (GLUTATHIONES-TRANSFERASE) | Carbocisteine | 4 / 7 | LEU b 25THR B 923LEU B 930GLY B 928 | 1.25A | 10.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P65_I_IPHI101_0 (INSULIN) | Phenol | 5 / 12 | LEU B 948LEU B 941ILE b 11LEU C 941LEU A 944 | 1.20A | 18.4615.91 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HM1_A_J3ZA2_1 (ESTROGEN RECEPTOR) | Estrone | 6 / 12 | THR A 923ALA A 926GLU c 21LEU C 930LEU c 18LEU B 927 | 1.74A | 16.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N8Y_A_DIFA701_1 (PROSTAGLANDIN G/HSYNTHASE 1) | Diclofenac | 5 / 11 | SER B 956ILE C 955GLY C 953ALA C 954SER C 950 | 1.43A | 10.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H2U_C_1N1C501_1 (PROTEIN-TYROSINEKINASE 6) | Dasatinib | 5 / 12 | LEU B 930ALA B 926LEU a 25THR B 922GLY A 928 | 1.30A | 14.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5L4I_A_6J3A201_0 (TRANSTHYRETIN) | Clonixin | 5 / 6 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.79A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EQG_A_IBPA701_1 (PROSTAGLANDIN H2SYNTHASE-1) | Ibuprofen | 5 / 9 | VAL A 945LEU B 944ILE c 11ALA A 940LEU A 941 | 1.32A | 8.93 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VCV_F_ASDF1224_1 (GLUTATHIONES-TRANSFERASE A3) | 4-Androstenedione | 5 / 8 | LEU c 18LEU c 16ALA C 926LEU B 930ALA B 926 | 1.68A | 14.43 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QKN_A_RALA600_1 (ESTROGEN RECEPTORBETA) | Raloxifene | 5 / 12 | LEU A 927THR A 925LEU c 25GLY C 928LEU c 18 | 1.42A | 21.74 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KW2_A_ADNA300_1 (PROBABLE R-RNAMETHYLTRANSFERASE) | Adenosine | 5 / 11 | SER B 924LEU B 927LEU b 18THR C 925ALA C 926 | 1.23A | 14.46 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TQ9_A_MTXA2001_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | LEU a 32ILE B 913LEU b 32ILE C 916THR A 923 | 1.26A | 16.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V0V_A_8QPA612_1 (SERUM ALBUMIN) | Etodolac | 5 / 12 | LYS a 24LEU b 25LEU C 927ALA B 926GLU a 21 | 1.47A | 6.49 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NPT_A_017A401_1 (PROTEASE) | Darunavir | 5 / 9 | ASN B 937ALA A 938ILE c 11ILE a 11VAL a 13 | 1.58A | 20.59 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TBF_A_VIAA501_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE) | Sildenafil | 5 / 9 | LEU A 948LEU c 8VAL c 13ALA C 938LEU B 941 | 1.54A | 14.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DQF_A_CZEA613_1 (SERUM ALBUMIN) | Cetirizine | 5 / 9 | ALA C 926ASP b 17LEU B 927LEU b 25GLU b 19 | 1.76A | 8.46 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | Acarbose | 5 / 12 | THR A 943ASN a 12VAL a 13ALA A 938GLN A 939 | 1.20A | 6.86 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TQB_A_FOLA2001_0 (DIHYDROFOLATEREDUCTASE) | Folic Acid | 5 / 11 | LEU a 32ILE B 913LEU b 32ILE C 916THR A 923 | 1.27A | 16.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5GTR_A_ESTA601_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 12 | ALA B 926MET a 22LEU a 25GLY A 928LEU A 930 | 1.51A | 15.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4M2X_C_TMQC202_1 (DIHYDROFOLATEREDUCTASE) | Trimetrexate | 5 / 12 | ILE C 913ILE A 913GLN A 915LEU C 920ILE C 916 | 1.40A | 21.48 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3BBT_D_FMMD91_1 (RECEPTORTYROSINE-PROTEINKINASE ERBB-4) | Lapatinib | 5 / 12 | ALA A 926LEU a 25THR A 923GLY C 928THR C 923 | 1.54A | 13.76 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HWI_B_115B1_2 (HMG-COA REDUCTASE) | Fluvastatin | 4 / 8 | SER B 949VAL B 945ASN b 12ASP b 9 | 1.70A | 11.23 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QKT_A_ESTA600_1 (ESTRADIOL RECEPTOR) | Estradiol | 5 / 10 | MET b 22LEU B 927ALA B 926LEU a 18LEU A 930 | 1.58A | 10.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IX9_B_MTXB200_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | ALA A 938LEU C 941LEU B 941GLN B 939VAL A 945 | 1.46A | 21.39 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FDY_U_DB8U301_1 (-) | Bosutinib | 5 / 11 | LEU B 948VAL B 945VAL a 13ASN C 937LEU A 941 | 1.58A | 17.86 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PCG_B_ESTB2_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 10 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.47A | 10.74 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NM5_B_LOCB502_2 (TUBULIN BETA-2BCHAIN) | Colchicine | 5 / 12 | LEU B 948LEU B 941LEU A 944ILE b 11ALA C 940 | 1.38A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GWX_B_EPAB3_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) | Icosapent | 5 / 12 | PHE B 909ILE b 29LEU C 920LEU c 32ILE C 913 | 1.46A | 19.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DVX_B_DIFB125_1 (TRANSTHYRETIN) | Diclofenac | 5 / 7 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.67A | 23.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QYN_B_RTLB201_0 (RETINOL-BINDINGPROTEIN 2) | Vitamin A | 5 / 12 | ILE b 29THR A 921THR A 923LEU c 25LEU C 920 | 1.60A | 14.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KOC_A_SAMA401_0 (PAVINEN-METHYLTRANSFERASE) | S-Adenosylmethionine | 6 / 12 | GLY C 928SER C 924ASN C 935VAL C 934ALA A 926LEU A 930 | 1.70A | 11.93 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XN7_A_T44A1355_1 (THYROXINE-BINDINGGLOBULIN) | Levothyroxine | 5 / 10 | LEU b 16LEU C 930SER B 924LEU B 927LEU b 18 | 1.22A | 8.5322.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EBP_D_DAHD123_0 (RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE,BETA SUBUNIT) | Levodopa | 5 / 10 | LEU B 920THR B 923SER A 919ILE C 916ILE A 916 | 1.49A | 14.93 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3R_A_9PLA501_1 (CYTOCHROME P450 2A6) | Pilocarpine | 5 / 11 | PHE B 952ASN C 951ILE C 955GLY C 953LEU c 8 | 1.46A | 11.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HJO_A_AQ4A1001_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | Erlotinib | 5 / 12 | LEU A 930ALA A 926THR A 923GLY C 928THR C 923 | 1.47A | 14.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JN3_A_JN3A131_2 (FATTY ACID-BINDINGPROTEIN, LIVER) | Ursodeoxycholic acid | 4 / 6 | LEU C 948ASN A 937GLN C 936ILE b 11 | 1.43A | 24.39 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W9G_A_TOPA1159_1 (DIHYDROFOLATEREDUCTASE) | Trimethoprim | 5 / 10 | LEU c 25ALA C 926LEU B 927LEU b 25THR C 925 | 1.47A | 13.16 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_B_9F2B301_1 (BETA-LACTAMASE) | Ceftriaxone | 5 / 12 | SER A 924THR B 923THR A 923GLY A 928ASP A 932 | 1.59A | 15.18 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1KNY_A_KANA558_1 (KANAMYCINNUCLEOTIDYLTRANSFERASE) | Kanamycin | 4 / 7 | ASP b 17GLU b 21GLU C 918GLU b 27 | 1.62A | 12.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BZF_A_TMQA170_1 (DIHYDROFOLATEREDUCTASE) | Trimetrexate | 5 / 12 | ALA A 926LEU c 25LEU b 25ALA B 926THR A 925 | 1.50A | 18.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LBC_A_CYZA330_1 (GLUTAMINE RECEPTOR 2) | Cyclothiazide | 5 / 12 | LEU C 920SER C 919LEU b 25LYS b 23ILE c 29 | 1.71A | 14.94 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZE0_A_VORA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) | Voriconazole | 5 / 9 | PHE A 909ILE A 913PHE B 909LEU b 32LEU B 920 | 1.65A | 11.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WG0_C_CHDC102_0 (NUCLEAR RECEPTORCOACTIVATOR 2) | Cholic Acid | 4 / 7 | LEU A 948ASN C 951LEU C 948LEU C 944 | 1.24A | 12.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DLZ_B_CYZB1302_0 (GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT) | Cyclothiazide | 5 / 10 | LEU C 920SER C 919LEU b 25LYS b 23ILE c 29 | 1.77A | 6.12 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BQG_A_ERMA1201_2 (5-HYDROXYTRYPTAMINERECEPTOR 2C,SOLUBLECYTOCHROME B562) | Ergotamine | 4 / 5 | THR a 14LEU C 941VAL B 945LEU A 948 | 1.33A | 7.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X20_D_LOCD502_2 (TUBULIN BETA CHAIN) | Colchicine | 5 / 11 | LEU A 944LEU B 944ASN B 942VAL a 13ILE a 11 | 1.20A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JFA_A_RALA600_1 (ESTROGEN RECEPTOR) | Raloxifene | 5 / 12 | THR A 923ALA A 926LEU A 930LEU c 18LEU c 25 | 1.42A | 16.45 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXQ_A_IMNA2001_1 (SERUM ALBUMIN) | Indomethacin | 5 / 10 | SER A 919ALA C 926LEU b 18LEU C 930LEU C 920 | 1.46A | 9.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EQG_B_IBPB1701_1 (PROSTAGLANDIN H2SYNTHASE-1) | Ibuprofen | 5 / 11 | VAL A 945LEU B 944ILE c 11ALA A 940LEU A 941 | 1.35A | 8.93 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AI9_X_SAMX501_0 (UPF0217 PROTEINMJ1640) | S-Adenosylmethionine | 5 / 9 | LEU c 25GLY C 928LEU C 920SER C 919GLU b 21 | 1.62A | 11.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LM8_D_VIBD223_1 (THIAMINEPYROPHOSPHOKINASE) | Thiamine | 4 / 8 | LEU C 948LEU A 944SER A 950ASN A 951 | 1.17A | 14.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZXW_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) | Cholic Acid | 4 / 7 | LEU A 948GLN A 947LEU B 948PHE B 952 | 1.38A | 18.2220.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QZU_C_RTLC201_0 (RETINOL-BINDINGPROTEIN 2) | Vitamin A | 5 / 12 | ILE C 916ALA b 28THR B 923LEU C 927LEU c 25 | 1.31A | 23.02 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MSD_A_BEZA1202_0 (CARBOXYLIC ACIDREDUCTASE) | Benzoic Acid | 4 / 5 | ILE A 916PHE A 909SER a 35ALA A 912 | 1.71A | 6.30 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KU1_H_SAMH226_0 (SAM-DEPENDENTMETHYLTRANSFERASE) | S-Adenosylmethionine | 5 / 12 | LEU a 25GLY A 928VAL A 933VAL A 934LEU c 18 | 1.31A | 15.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W3M_A_FOLA1188_0 (DIHYDROFOLATEREDUCTASE) | Folic Acid | 5 / 12 | ALA B 926LEU a 25GLN B 917ILE A 916THR B 925 | 1.43A | 17.68 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J24_D_ESTD600_1 (ESTROGEN RECEPTORBETA) | Estradiol | 5 / 12 | LEU B 927ALA B 926LEU C 927LEU c 18LEU a 16 | 1.39A | 20.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ILU_B_HFZB800_1 (GLUTAMATE RECEPTOR 2) | Hydroflumethiazide | 5 / 10 | SER b 7LEU B 959ILE B 955SER B 949GLY B 953 | 1.44A | 10.98 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NP1_A_HSMA303_1 (NITROPHORIN 1) | Histamine | 4 / 5 | GLU b 19LEU B 927LEU b 18LEU b 25 | 1.51A | 17.81 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DQF_A_LCRA612_1 (SERUM ALBUMIN) | Cetirizine | 5 / 9 | LYS B 929LEU B 930LEU C 930LEU b 18ALA C 926 | 1.37A | 8.46 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OU1_A_BEZA302_0 (RETRO-ALDOLASE,DESIGN RA114) | Benzoic Acid | 4 / 8 | ILE A 905LYS A 903ILE B 905ASN B 901 | 1.23A | 17.37 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QXS_A_RALA600_1 (ESTROGEN RECEPTOR) | Raloxifene | 5 / 12 | THR B 923ALA B 926LEU A 930LEU a 18LEU a 25 | 1.39A | 14.96 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YVP_B_GBMB402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C1) | Glyburide | 5 / 12 | LEU A 941VAL a 13ILE a 11LEU C 948LEU A 948 | 1.39A | 14.06 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SNF_A_ACTA110_0 (PROTEIN P-30) | Acetic acid | 4 / 5 | ILE c 29THR C 921THR C 923SER C 924 | 1.40A | 18.63 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z90_F_4LEF401_1 (GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNITBETA-1) | Isoflurane | 5 / 8 | LEU A 920THR A 922THR C 923LEU C 920THR B 923 | 1.34A | 13.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QWU_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 11 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.68A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HWK_A_117A2_1 (HMG-COA REDUCTASE) | Atorvastatin | 4 / 8 | SER B 949VAL B 945ASN b 12ASP b 9 | 1.71A | 11.23 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QHY_A_CLMA999_0 (CHLORAMPHENICOLPHOSPHOTRANSFERASE) | Chloramphenicol | 5 / 12 | ILE B 913ILE B 916ILE A 916LEU c 32GLN C 917 | 1.35A | 21.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CZH_A_D2VA602_2 (CYTOCHROME P450 2R1) | Ergocalciferol | 3 / 3 | LEU A 920GLU B 918ILE B 916 | 0.99A | 13.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HJH_A_NCAA900_0 (NAD-DEPENDENTHISTONE DEACETYLASESIR2) | Nicotinamide | 4 / 5 | ILE A 913PHE C 909PHE B 909ILE C 916 | 1.44A | 13.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MTE_B_SAMB220_0 (16S RRNA METHYLASE) | S-Adenosylmethionine | 5 / 12 | VAL C 933ALA C 926GLU b 21LEU a 18LEU B 927 | 1.44A | 18.09 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IEN_B_VDYB201_2 (CDL2.2) | Calcidiol | 5 / 12 | LEU c 18LEU A 920LEU C 927ALA B 926LEU b 25 | 1.47A | 17.86 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OLS_A_ESTA600_1 (ESTROGEN RECEPTORBETA) | Estradiol | 5 / 12 | LEU B 927ALA B 926LEU A 927LEU C 927LEU a 16 | 1.40A | 20.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NNI_A_MTKA501_2 (CYTOCHROME P450 2C8) | Montelukast | 5 / 8 | ILE A 916ILE A 913ILE C 916ASN B 910ALA A 906 | 1.54A | 11.11 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UDU_B_CIAB2003_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE) | Tadalafil | 5 / 12 | ALA A 906ILE A 905ILE a 37ALA B 912PHE C 909 | 1.47A | 15.21 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z90_A_4LEA401_1 (GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNITBETA-1) | Isoflurane | 6 / 8 | LEU C 927ALA C 926LEU C 930LEU B 930ALA B 926LEU A 927 | 1.41A | 13.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WRK_A_TFPA204_1 (TROPONIN C, SLOWSKELETAL AND CARDIACMUSCLES) | Trifluoperazine | 5 / 9 | PHE C 952VAL B 945LEU B 944PHE B 952LEU C 944 | 1.69A | 24.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YVN_A_ACTA305_0 (GLUTATHIONES-TRANSFERASEOMEGA-1) | Acetic acid | 4 / 6 | GLU c 21GLN C 931LEU A 930LEU C 927 | 1.36A | 13.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) | Ponatinib | 5 / 12 | ALA A 926LEU b 18LEU B 930LEU a 18ALA B 926 | 1.35A | 13.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OU6_D_SAMD300_0 (SAM-DEPENDENTMETHYLTRANSFERASE) | S-Adenosylmethionine | 5 / 12 | LEU b 18GLU a 21ALA B 926GLY B 928LEU B 930 | 1.66A | 11.76 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QTU_D_SAMD301_1 (PUTATIVEMETHYLTRANSFERASEBUD23) | S-Adenosylmethionine | 4 / 5 | GLN C 915LEU b 32SER b 35ASP c 38 | 1.16A | 19.70 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JB3_A_SAMA1102_1 (STRUCTURAL PROTEINVP3) | S-Adenosylmethionine | 3 / 3 | ARG B 965ASP B 967ASP B 961 | 1.66A | 5.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O96_G_SAMG501_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE E) | S-Adenosylmethionine | 5 / 11 | LEU B 930GLY B 928LEU A 930VAL C 933GLU b 21 | 1.33A | 15.29 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LJB_A_RTLA201_1 (RETINOL-BINDINGPROTEIN 1) | Vitamin A | 4 / 8 | LEU b 25LEU C 927ILE a 29GLN A 917 | 1.48A | 17.92 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QGT_A_CP6A609_1 (BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) | Pyrimethamine | 5 / 10 | ILE B 913ALA B 912PHE B 909SER c 35ILE c 37 | 1.64A | 9.59 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OZU_A_X89A411_1 (FLAVOHEMOPROTEIN) | Miconazole | 5 / 12 | ILE A 916LEU A 920LEU C 920ALA C 926LEU C 927 | 1.34A | 11.41 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LN1_D_CELD682_1 (PROSTAGLANDIN G/HSYNTHASE 2) | Celecoxib | 5 / 12 | LEU a 25ALA b 28GLY B 928ALA B 926LEU a 18 | 1.47A | 6.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IIL_A_RBFA401_2 (MEMBRANE LIPOPROTEINTPN38(B)) | Riboflavin | 4 / 8 | VAL C 945ASN c 12GLN A 947GLN A 936 | 1.42A | 12.75 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DTL_A_BEPA205_1 (CARDIAC TROPONIN C) | Bepridil | 5 / 12 | ALA B 912ILE B 913PHE A 909LEU c 32LEU B 920 | 1.43A | 21.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FHZ_B_REAB602_1 (ALDEHYDEDEHYDROGENASE FAMILY1 MEMBER A3) | Tretinoin | 5 / 9 | THR B 923LEU C 927GLN A 936LEU B 930LEU B 927 | 1.64A | 9.98 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZXW_P_CHDP1271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) | Cholic Acid | 4 / 6 | LEU A 948GLN A 947LEU B 948PHE B 952 | 1.51A | 18.2220.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DZY_D_BRLD478_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | Rosiglitazone | 4 / 4 | ILE B 913GLN C 904ILE C 913LEU b 39 | 1.43A | 15.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XO7_A_ASDA402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2) | 4-Androstenedione | 4 / 7 | VAL a 13ILE a 11LEU C 948LEU A 948 | 1.39A | 9.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXF_A_DZPA2001_1 (SERUM ALBUMIN) | Diazepam | 5 / 12 | ILE c 11LEU B 948LEU B 944VAL A 945LEU A 941 | 1.43A | 5.68 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XOO_A_ADNA506_1 (GLYCOSAMINOGLYCANXYLOSYLKINASE) | Adenosine | 4 / 6 | LEU A 930LYS c 24GLU c 21LEU c 18 | 1.79A | 14.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XUM_A_IMNA502_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | Indomethacin | 4 / 7 | GLU b 33ILE b 29LEU A 920ILE B 916 | 1.50A | 17.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V96_A_ADNA502_2 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) | Adenosine | 4 / 4 | GLU B 918THR B 922THR A 922LEU C 920 | 1.77A | 12.41 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4W5N_A_IPHA902_0 (PROTEIN ARGONAUTE-2) | Phenol | 4 / 6 | LEU B 930LYS B 929LEU a 18GLU a 21 | 1.43A | 8.42 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1Y_D_LOCD502_2 (TUBULIN BETA CHAIN) | Colchicine | 5 / 12 | LEU A 920LEU C 920ALA A 912ALA c 28ILE A 913 | 1.14A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VE3_B_REAB1445_1 (PUTATIVE CYTOCHROMEP450 120) | Tretinoin | 5 / 12 | THR B 922ALA a 28THR A 922GLY A 928GLN A 931 | 1.53A | 14.29 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DC3_A_ADNA401_1 (ADENOSINE KINASE) | Adenosine | 5 / 12 | LEU c 25GLY B 928ALA B 926THR C 923LEU C 927 | 1.30A | 9.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ILU_E_HFZE800_1 (GLUTAMATE RECEPTOR 2) | Hydroflumethiazide | 5 / 11 | ILE B 955SER B 949GLY B 953SER b 7LEU B 959 | 1.41A | 15.12 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3A50_D_VD3D2001_1 (VITAMIN DHYDROXYLASE) | Cholecalciferol | 5 / 12 | ILE C 916LEU c 32ILE A 913ALA B 912LEU A 920 | 1.23A | 11.76 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K4Y_A_ACTA502_0 (RNA-DEPENDENT RNAPOLYMERASE) | Acetic acid | 4 / 5 | LYS a 24LEU a 25GLU a 21LEU A 927 | 1.78A | 9.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FHZ_C_REAC602_1 (ALDEHYDEDEHYDROGENASE FAMILY1 MEMBER A3) | Tretinoin | 5 / 10 | THR B 923LEU C 927GLN A 936LEU B 930LEU B 927 | 1.57A | 9.98 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DFR_A_MTXA164_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | LEU a 25LEU C 920LEU B 920SER C 924LEU B 927 | 1.52A | 10.49 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_D_29SD601_1 (ESTROGEN RECEPTOR) | Bazedoxifene | 5 / 12 | THR B 923ALA B 926LEU A 930LEU a 18LEU a 25 | 1.36A | 15.10 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MX1_C_THAC3_1 (LIVERCARBOXYLESTERASE I) | Tacrine | 5 / 12 | LEU a 18GLY A 928LEU c 16LEU B 930MET c 22 | 1.23A | 9.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1F_A_3WFA501_1 (NUCLEAR RECEPTORSUBFAMILY 1 GROUP IMEMBER 2) | Ethinyl Estradiol | 5 / 12 | ASP c 9LEU c 8LEU A 944PHE c 15ILE c 11 | 1.55A | 12.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DB1_A_VDXA428_1 (VITAMIN D NUCLEARRECEPTOR) | Calcitriol | 5 / 12 | LEU a 25LEU A 920SER A 919SER C 919LEU A 930 | 1.34A | 12.55 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IIZ_B_LURB201_1 (TRANSTHYRETIN) | Lumiracoxib | 4 / 8 | LYS B 929LEU a 16THR B 925ALA B 926 | 1.31A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OAX_B_SNLB2001_1 (MINERALOCORTICOIDRECEPTOR) | Spironolactone | 5 / 12 | LEU c 16LEU b 16GLN B 931LEU B 927LEU a 18 | 1.31A | 12.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z91_E_4LEE401_1 (GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNITBETA-1) | Isoflurane | 6 / 10 | THR C 923LEU B 927LEU C 930LEU A 930THR A 923LEU A 927 | 1.58A | 13.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QW3_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 10 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.69A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z90_A_4LEA401_1 (GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNITBETA-1) | Isoflurane | 6 / 8 | LEU a 18LEU A 927LEU C 927ALA C 926LEU C 930LEU B 930 | 1.77A | 9.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RMJ_A_NCAA402_0 (NAD-DEPENDENTPROTEIN DEACETYLASESIRTUIN-2) | Nicotinamide | 4 / 7 | LEU C 944LEU A 944ASN c 12ILE c 11 | 1.01A | 11.49 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ACL_A_SASA1111_1 (MCG) | Sulfasalazine | 4 / 7 | TYR a 36SER a 35GLU a 33PHE A 909 | 1.79A | 18.45 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AZ3_1_PAR11803_1 (RRNA ALPHARIBOSOMAL PROTEINEL18) | Paromomycin | 3 / 3 | SER A 949LYS A 946SER A 950 | 1.55A | 20.54 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3E00_A_9CRA7223_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) | Alitretinoin | 5 / 12 | ILE B 913ALA C 912GLN C 915ALA b 28ILE A 913 | 1.48A | 11.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTI_A_CCSA47_0 (GLUTATHIONES-TRANSFERASE) | Carbocisteine | 4 / 7 | LEU a 25THR A 923GLY A 928LEU a 18 | 1.11A | 10.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TQ8_A_TOPA2001_1 (DIHYDROFOLATEREDUCTASE) | Trimethoprim | 5 / 9 | ALA b 28LEU B 920SER A 919ILE A 916ILE C 913 | 1.35A | 16.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PFJ_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) | Adenosine | 4 / 7 | GLU b 21THR C 925THR A 923LEU B 920 | 1.56A | 6.87 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QB4_A_DSMA801_1 (TRANSPORTER) | Desipramine | 5 / 12 | LEU c 32ILE C 916PHE C 909ALA B 912LEU b 32 | 1.49A | 5.84 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_B_9F2B301_1 (BETA-LACTAMASE) | Ceftriaxone | 5 / 12 | SER C 924THR A 923THR C 923GLY C 928ASP C 932 | 1.57A | 15.18 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X7Z_A_BHAA201_0 (UNCHARACTERIZEDHTH-TYPETRANSCRIPTIONALREGULATOR RV2887) | Aminosalicylic Acid | 4 / 6 | LEU B 930VAL B 934LEU b 16VAL C 934 | 1.29A | 20.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DM1_B_CYZB1302_0 (GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT) | Cyclothiazide | 5 / 10 | LEU C 920SER C 919LEU b 25LYS b 23ILE c 29 | 1.76A | 6.12 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HYR_B_ESTB601_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 11 | LEU B 927ALA B 926LEU A 927LEU C 927LEU a 16 | 1.50A | 16.06 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HA2_A_SWFA3001_1 (SERUM ALBUMIN) | Warfarin | 5 / 11 | ALA A 940LEU A 941LEU B 944ILE b 11ALA C 940 | 1.43A | 9.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2A15_A_NCAA1001_0 (HYPOTHETICAL PROTEINRV0760C) | Nicotinamide | 5 / 11 | SER B 949VAL B 945ILE b 11LEU C 944LEU C 948 | 1.61A | 18.18 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1G_A_3WFA501_1 (NUCLEAR RECEPTORSUBFAMILY 1 GROUP IMEMBER 2) | Ethinyl Estradiol | 5 / 12 | ASP c 9LEU c 8LEU A 944PHE c 15ILE c 11 | 1.54A | 12.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OIP_B_MTXB609_1 (CHAIN A, CRYSTALSTRUCTURE OF DHFR) | Methotrexate | 5 / 12 | ALA A 926LEU C 927LEU c 25LEU B 920THR A 925 | 1.58A | 10.66 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D1Y_A_RBFA1176_1 (PUTATIVE PROTEASE I) | Riboflavin | 4 / 8 | GLN B 936ASN B 935LYS B 946THR B 943 | 1.59A | 18.48 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | Bicalutamide | 5 / 12 | LEU C 930ALA B 926THR B 923ALA C 926THR C 923 | 1.33A | 12.41 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVM_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 10 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.70A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GWX_A_EPAA1_1 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) | Icosapent | 5 / 10 | VAL C 933GLN C 939LEU A 930VAL A 934LEU C 930 | 1.37A | 19.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XOY_A_DX4A401_0 (MITOGEN-ACTIVATEDPROTEIN KINASE 1) | Tioguanine | 4 / 6 | ALA C 926LYS C 929LEU B 927MET b 22 | 1.68A | 15.20 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IEP_B_STIB202_1 (PROTO-ONCOGENETYROSINE-PROTEINKINASE ABL) | Imatinib | 5 / 12 | LEU B 930ALA B 926ILE A 916THR B 923GLY A 928 | 1.34A | 14.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIM_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) | Cholic Acid | 4 / 7 | LYS A 946LEU A 948PHE A 952LEU B 948 | 1.33A | 18.2220.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DLZ_D_CYZD1302_0 (GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT) | Cyclothiazide | 5 / 11 | ILE c 29LEU C 920SER C 919LEU b 25LYS b 23 | 1.77A | 3.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SKX_A_RFPA1_2 (ORPHAN NUCLEARRECEPTOR PXR) | Rifampicin | 4 / 5 | LYS B 903PHE C 909LEU b 39LEU a 32 | 1.71A | 15.10 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XKW_A_P1BA1478_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | Pioglitazone | 4 / 7 | GLU b 27ILE b 29ALA A 912ILE A 913 | 1.11A | 17.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3S_B_9PLB1_1 (CYTOCHROME P450 2A13) | Pilocarpine | 4 / 6 | PHE b 15ASN B 937ALA B 940THR B 943 | 1.48A | 8.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QWP_A_GCSA303_1 (CHITOSANASE) | Glucosamine | 4 / 6 | GLU A 918ILE a 29THR A 921TYR a 36 | 1.42A | 19.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q0D_C_MTXC604_1 (BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) | Methotrexate | 5 / 12 | ALA A 926LEU C 927LEU c 25LEU B 920THR A 925 | 1.60A | 9.74 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XXI_A_LSNA501_1 (CYTOCHROME P450 2C9) | Losartan | 5 / 12 | VAL C 958ASN A 951GLY C 953ALA C 954LEU B 959 | 1.36A | 12.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDING GLOBULIN) | Hydrocortisone | 5 / 12 | SER B 949VAL B 945GLN C 936THR b 14ILE b 11 | 1.54A | 13.51 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NWU_A_ACAA18_1 (WTFP-TAG,GP41) | Aminocaproic Acid | 5 / 12 | ALA C 926SER C 924GLU C 918GLN C 917GLU c 33 | 1.51A | 20.29 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HI2_A_BAXA801_2 (SERINE/THREONINE-PROTEIN KINASE B-RAF) | Sorafenib | 5 / 8 | ILE b 11VAL C 958ILE A 955ILE B 955PHE B 952 | 1.62A | 10.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DVT_A_FLPA125_1 (TRANSTHYRETIN) | Flurbiprofen | 5 / 8 | LEU C 944LEU C 941LEU c 18LEU c 16THR c 14 | 1.70A | 23.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A7T_A_5FWA1000_1 (SUPEROXIDE DISMUTASE[CU-ZN]) | Isoprenaline | 4 / 6 | GLU b 26LYS b 30LYS b 24GLU C 918 | 1.45A | 17.05 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BZO_C_FI8C1201_0 (DNA-DIRECTED RNAPOLYMERASE SUBUNITBETA) | Fidaxomicin | 5 / 12 | THR A 894GLN A 895THR B 894VAL B 897VAL B 893 | 1.63A | 6.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KP6_A_SALA3002_1 (TRANSCRIPTIONALREGULATOR TCAR) | Salicylic acid | 5 / 8 | LEU A 941VAL C 945LEU C 944ILE c 11LEU A 948 | 1.23A | 27.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZOW_A_CLMA500_0 (MULTIDRUGTRANSPORTER MDFA) | Chloramphenicol | 6 / 11 | LEU C 930LEU c 18LEU A 920LEU b 25LEU B 927LEU B 920 | 1.79A | 13.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IKJ_B_SUZB201_1 (TRANSTHYRETIN) | Sulindac | 5 / 8 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.77A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IFU_A_GBMA801_1 (PROLINE--TRNA LIGASE) | Glyburide | 5 / 12 | TYR b 36LEU a 32GLU B 918ILE B 916ILE B 913 | 1.58A | 7.36 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Q72_A_IXXA801_1 (TRANSPORTER) | Imipramine | 5 / 11 | LEU c 32ILE C 916PHE C 909ALA B 912LEU b 32 | 1.46A | 5.84 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QD4_A_CHDA801_0 (FERROCHELATASE) | Cholic Acid | 5 / 12 | LEU B 941LEU C 941GLN B 947LEU c 8VAL A 945 | 1.51A | 14.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVN_V_BO2V301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 10 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.65A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QWP_B_GCSB302_1 (CHITOSANASE) | Glucosamine | 4 / 5 | GLU A 918ILE a 29THR A 921TYR a 36 | 1.44A | 19.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2V0M_C_KLNC1498_1 (CYTOCHROME P450 3A4) | Ketoconazole | 5 / 12 | SER A 956LEU B 948PHE C 952ILE B 955ALA B 954 | 1.46A | 11.78 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERR_A_RALA600_2 (ESTROGEN RECEPTOR) | Raloxifene | 4 / 6 | LEU c 25LEU c 32LEU B 927LEU B 930 | 0.87A | 11.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CZ7_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 11 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.65A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y7P_B_CHDB401_0 (BILE SALT HYDROLASE) | Cholic Acid | 5 / 10 | ILE a 11LEU B 944ASN A 937ALA A 940LEU C 941 | 1.54A | 10.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YI4_A_ADNA306_1 (PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE PIM-1) | Adenosine | 5 / 10 | LEU a 25ILE B 916LEU B 920LEU a 32ILE A 916 | 1.51A | 17.10 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QKN_A_JMSA602_1 (ALPHA-KETOGLUTARATE-DEPENDENTDIOXYGENASE FTO) | Meclofenamic acid | 4 / 8 | LEU A 927THR A 925LEU C 927SER A 919 | 1.38A | 10.55 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z91_J_4LEJ401_1 (GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNITBETA-1) | Isoflurane | 6 / 9 | LEU A 930LEU C 930ALA C 926LEU B 927LEU A 927ALA A 926 | 1.32A | 13.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JIP_A_KTNA801_1 (CYTOCHROME P450107A1) | Ketoconazole | 6 / 12 | ALA A 940LEU C 944VAL a 13ALA B 940THR c 14LEU C 941 | 1.71A | 11.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2DYS_C_CHDC310_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) | Cholic Acid | 4 / 7 | LYS A 946LEU A 948PHE A 952LEU B 948 | 1.40A | 18.2220.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MX1_E_THAE5_2 (LIVERCARBOXYLESTERASE I) | Tacrine | 3 / 3 | PHE B 952LEU C 948LEU C 944 | 0.87A | 11.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V96_A_ADNA502_2 (S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE) | Adenosine | 4 / 4 | GLU b 21THR C 925THR A 923LEU B 920 | 1.68A | 5.84 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TYR_A_9CRA131_1 (TRANSTHYRETIN) | Alitretinoin | 4 / 6 | LEU b 25LEU B 920SER B 919THR A 923 | 1.33A | 22.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TAV_B_CFFB5102_1 (RYANODINE RECEPTOR 1) | Caffeine | 4 / 7 | GLU a 33ILE a 29ILE A 916TYR a 36 | 1.65A | 1.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W68_D_VIVD301_0 (ALPHA-TOCOPHEROLTRANSFER PROTEIN) | Vitamin E | 5 / 12 | LEU b 8ILE c 11VAL B 945LEU B 941VAL b 13 | 1.30A | 9.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V8B_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) | Adenosine | 3 / 3 | GLU a 19GLU a 27LEU A 920 | 1.19A | 6.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DH0_A_SAMA220_0 (SAM DEPENDENTMETHYLTRANSFERASE) | S-Adenosylmethionine | 5 / 12 | LEU A 930SER B 919ALA C 926THR C 923LEU C 920 | 1.45A | 16.20 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1G_A_LNLA701_1 (PROSTAGLANDIN G/HSYNTHASE 2) | Alpha-Linolenic Acid | 5 / 12 | PHE A 952GLY A 953ALA A 954SER A 956LEU A 959 | 1.54A | 8.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Z11_C_8MOC501_0 (CYTOCHROME P450,FAMILY 2, SUBFAMILYA, POLYPEPTIDE 6) | Methoxsalen | 5 / 10 | PHE B 952ASN C 951ILE C 955GLY C 953LEU c 8 | 1.41A | 11.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1K_D_LOCD502_2 (TUBULIN BETA CHAIN) | Colchicine | 5 / 12 | LEU A 920LEU C 920ALA A 912ALA c 28ILE A 913 | 1.23A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G9B_A_IXXA609_1 (ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEINENVELOPEGLYCOPROTEIN) | Imipramine | 5 / 7 | ILE b 11LEU b 8LEU B 948LEU B 944LEU c 8 | 1.52A | 9.2310.49 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O1C_A_ADNA127_1 (HISTIDINE TRIADNUCLEOTIDE-BINDINGPROTEIN 1) | Adenosine | 5 / 10 | ILE B 955PHE B 952ILE C 955SER A 949LEU C 948 | 1.36A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N09_A_ADNA401_2 (ADENOSINE KINASE) | Adenosine | 4 / 4 | LEU A 944SER A 949LEU B 948LEU A 941 | 1.50A | 13.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K4Y_E_ACTE503_0 (RNA-DEPENDENT RNAPOLYMERASE) | Acetic acid | 4 / 4 | LYS A 929LEU A 930GLU c 21LEU C 927 | 1.25A | 12.39 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LM8_A_VIBA223_1 (THIAMINEPYROPHOSPHOKINASE) | Thiamine | 4 / 7 | LEU C 948LEU A 944SER A 950ASN A 951 | 1.29A | 14.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDING GLOBULIN) | Hydrocortisone | 5 / 12 | SER B 949VAL B 945GLN C 936THR b 14ILE b 11 | 1.48A | 13.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IX9_A_MTXA200_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | LEU a 18LEU B 930GLN B 931VAL A 933THR a 14 | 1.47A | 13.16 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HZP_A_FVTA501_0 (PEPTIDE ABCTRANSPORTER PERMEASE) | Aminolevulinic acid | 4 / 8 | VAL B 933ASN B 937GLN A 939ASN A 942 | 1.49A | 10.12 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VKQ_C_PCFC1801_0 (NO MECHANORECEPTORPOTENTIAL C ISOFORML) | Colfosceril palmitate | 5 / 9 | ILE b 29TYR b 20ILE C 916ILE A 916LEU a 32 | 1.79A | 2.48 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SG9_A_SAMA301_0 (HEMK PROTEIN) | S-Adenosylmethionine | 5 / 12 | ILE B 955GLY C 953VAL C 958SER C 957ASN A 951 | 1.64A | 16.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZGF_A_BEZA210_0 (UNCHARACTERIZEDPROTEIN) | Benzoic Acid | 4 / 4 | VAL C 934ALA C 938ASN C 942GLN C 939 | 1.65A | 21.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AA6_B_STRB402_1 (MINERALOCORTICOIDRECEPTOR) | Progesterone | 5 / 12 | LEU B 927ALA B 926LEU B 920LEU A 920THR A 925 | 1.57A | 16.41 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6A5Z_D_9CRD501_0 (RETINOIC ACIDRECEPTOR RXR-ALPHA) | Alitretinoin | 6 / 12 | ILE A 916GLN B 915ILE B 913LEU A 920ALA a 28ILE C 913 | 1.67A | 15.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D7B_B_TCWB1126_1 (TRANSTHYRETIN) | Tolcapone | 5 / 7 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.70A | 22.66 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AG1_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE 7A1CYTOCHROME C OXIDASESUBUNIT 3) | Cholic Acid | 4 / 6 | LEU A 948GLN A 947LEU B 948PHE B 952 | 1.40A | 18.2220.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DEU_B_SALB306_1 (TRANSCRIPTIONALREGULATOR SLYA) | Salicylic acid | 4 / 6 | THR A 923THR C 923LEU B 920THR B 923 | 1.06A | 21.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1G5Y_C_9CRC502_1 (RETINOIC ACIDRECEPTOR RXR-ALPHA) | Alitretinoin | 5 / 10 | ALA B 954LEU B 959PHE B 952PHE A 952ILE B 955 | 1.58A | 15.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YA3_B_STRB2001_1 (MINERALOCORTICOIDRECEPTOR) | Progesterone | 5 / 12 | LEU B 927ALA A 926SER A 919LEU A 920LEU C 920 | 1.17A | 17.28 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LN1_B_CELB682_2 (PROSTAGLANDIN G/HSYNTHASE 2) | Celecoxib | 4 / 7 | SER C 950LEU A 948ILE C 955PHE C 952 | 1.30A | 8.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B0I_B_TA1B502_1 (TUBULIN BETA CHAIN) | Paclitaxel | 5 / 12 | VAL B 934ASP B 932LEU c 18LEU c 16LEU a 18 | 1.37A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QRC_A_0LIA802_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 4) | Ponatinib | 5 / 8 | LEU A 944VAL C 945LYS C 946ILE b 11LEU B 941 | 1.60A | 13.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2RIW_A_T44A1395_1 (THYROXINE-BINDINGGLOBULIN) | Levothyroxine | 5 / 10 | LEU C 941LEU A 944LEU B 944LYS B 946LEU A 941 | 1.47A | 14.6026.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MUO_A_ADNA1_1 (AURORA-RELATEDKINASE 1) | Adenosine | 5 / 9 | LEU B 927GLY B 928ALA C 926ALA A 926LEU A 930 | 1.47A | 16.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W9S_A_TOPA1160_1 (DIHYDROFOLATEREDUCTASE TYPE 1FROM TN4003) | Trimethoprim | 5 / 11 | ALA b 28LEU B 920ILE B 913SER A 919ILE A 916 | 1.46A | 18.42 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EM0_B_CHDB500_0 (ILEAL BILEACID-BINDING PROTEIN) | Cholic Acid | 4 / 7 | THR B 922GLU B 918SER B 914THR B 921 | 1.25A | 17.99 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6F32_B_ACTB602_0 (AMINE OXIDASE LKCE) | Acetic acid | 4 / 6 | ASN A 935VAL A 934VAL a 13THR a 14 | 1.72A | 11.75 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O0W_A_ADNA501_1 (AURORA KINASE A) | Adenosine | 4 / 6 | LEU C 927GLY C 928ALA A 926LEU B 930 | 0.96A | 16.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXF_A_DZPA2001_1 (SERUM ALBUMIN) | Diazepam | 5 / 12 | ASN C 951PHE B 952LEU B 948LEU A 948LEU c 8 | 1.49A | 9.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PYY_A_STIA3_1 (V-ABL ABELSON MURINELEUKEMIA VIRALONCOGENE HOMOLOG 1ISOFORM B VARIANT) | Imatinib | 5 / 12 | LEU B 930ALA B 926ILE A 916THR B 923GLY A 928 | 1.30A | 14.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KPC_A_SAMA401_1 (PAVINEN-METHYLTRANSFERASE) | S-Adenosylmethionine | 4 / 5 | PHE B 952SER B 949ASN B 960ASP B 961 | 1.58A | 11.93 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O1X_A_ADNA1450_1 (HISTIDINE TRIADNUCLEOTIDE-BINDINGPROTEIN 1) | Adenosine | 5 / 10 | ILE B 955PHE B 952ILE C 955SER A 949LEU C 948 | 1.58A | 23.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIN_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) | Cholic Acid | 4 / 7 | LYS A 946LEU A 948PHE A 952LEU B 948 | 1.37A | 18.2220.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) | Ponatinib | 5 / 12 | LEU c 25LEU C 927THR A 923LEU C 930ALA C 926 | 1.36A | 11.03 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2GJ5_A_VD3A163_1 (BETA-LACTOGLOBULIN) | Cholecalciferol | 5 / 12 | LEU C 898LEU c 39ILE A 905ILE B 905ALA B 906 | 1.34A | 20.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWJ_A_BAXA1723_2 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) | Sorafenib | 4 / 7 | ILE A 955LEU B 944ILE b 11PHE B 952 | 1.25A | 18.18 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NPN_A_SAMA4633_0 (PUTATIVE COBALAMINSYNTHESIS RELATEDPROTEIN) | S-Adenosylmethionine | 5 / 9 | THR A 925GLY A 928LEU A 930ALA A 926LEU B 927 | 1.57A | 16.09 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y7Z_B_IREB401_0 (CYCLIN-G-ASSOCIATEDKINASE) | Gefitinib | 5 / 12 | LEU A 930ALA A 926LEU a 25LEU c 18GLY C 928 | 1.34A | 15.44 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4TWD_C_377C401_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) | Memantine | 4 / 6 | ASN A 907GLU A 900TYR A 899LEU a 39 | 1.42A | 13.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AYL_B_FLPB2701_1 (PROSTAGLANDIN G/HSYNTHASE 1) | Flurbiprofen | 5 / 12 | VAL A 945LEU B 944ILE c 11ALA A 940LEU A 941 | 1.35A | 10.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D7B_A_TCWA1126_1 (TRANSTHYRETIN) | Tolcapone | 5 / 6 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.70A | 22.66 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5D0X_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 12 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.67A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H2U_B_1N1B501_1 (PROTEIN-TYROSINEKINASE 6) | Dasatinib | 6 / 12 | LEU B 930ALA B 926LEU a 25THR B 922LEU a 18GLY A 928 | 1.44A | 14.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BR4_C_SAMC301_0 (CEPHALOSPORINHYDROXYLASE CMCI) | S-Adenosylmethionine | 5 / 12 | LEU A 930LEU c 18GLY C 928ASP b 17ALA C 926 | 1.45A | 16.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OAX_D_SNLD4001_1 (MINERALOCORTICOIDRECEPTOR) | Spironolactone | 5 / 12 | LEU c 16LEU b 16GLN B 931LEU B 927LEU a 18 | 1.29A | 12.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ERD_A_DESA600_1 (ESTROGEN RECEPTORALPHA) | Diethylstilbestrol | 5 / 12 | MET b 22LEU B 927ALA B 926LEU a 18LEU A 930 | 1.58A | 11.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OR0_B_NPSB603_1 (SERUM ALBUMIN) | Naproxen | 5 / 11 | LEU C 930VAL B 933LEU a 16LEU b 16LEU A 930 | 1.64A | 8.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DXG_B_ESTB601_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 11 | LEU B 927ALA B 926LEU A 927LEU C 927LEU a 16 | 1.50A | 16.13 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5W97_C_CHDC306_0 (CYTOCHROME C OXIDASESUBUNIT 3CYTOCHROME C OXIDASESUBUNIT 7A1,MITOCHONDRIAL) | Cholic Acid | 4 / 6 | LYS A 946LEU A 948PHE A 952LEU B 948 | 1.43A | 18.2220.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DM1_D_CYZD1302_0 (GLUTAMATE RECEPTOR2,VOLTAGE-DEPENDENTCALCIUM CHANNELGAMMA-2 SUBUNIT) | Cyclothiazide | 5 / 11 | ILE c 29LEU C 920SER C 919LEU b 25LYS b 23 | 1.77A | 3.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CLD_B_GW6B2_2 (GLUCOCORTICOIDRECEPTOR) | Fluticasone furoate | 4 / 8 | LEU A 944ALA B 940LEU B 941GLN A 939 | 1.15A | 20.99 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VMY_B_FFOB505_0 (SERINEHYDROXYMETHYLTRANSFERASE) | Levoleucovorin | 5 / 12 | LEU a 18GLY A 928SER A 924ALA A 926GLY B 928 | 1.37A | 8.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UUD_A_ESTA600_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 11 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.53A | 11.02 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_D_ZPCD1318_1 (CYS-LOOPLIGAND-GATED IONCHANNEL) | Eszopiclone | 4 / 8 | PHE b 15VAL b 13ILE b 11ASN b 12 | 1.24A | 9.60 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VEU_H_RITH602_1 (CYTOCHROME P450 3A5) | Ritonavir | 5 / 12 | SER A 956PHE B 952PHE C 952ILE B 955ALA B 954 | 1.36A | 11.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RX3_A_MTXA161_2 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 3 / 3 | LYS a 31ILE A 913THR A 921 | 1.18A | 18.02 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ND7_B_TA1B601_1 (TUBULIN BETA-2BCHAIN) | Paclitaxel | 5 / 12 | VAL c 13LEU B 944LEU A 941ALA A 940LEU c 8 | 1.39A | 6.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H2U_A_1N1A501_1 (PROTEIN-TYROSINEKINASE 6) | Dasatinib | 6 / 12 | LEU A 930ALA A 926LEU c 25THR A 922LEU c 18GLY C 928 | 1.47A | 14.40 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JB1_A_SAMA1101_0 (STRUCTURAL PROTEINVP3) | S-Adenosylmethionine | 5 / 12 | ILE B 913ALA C 906ALA A 912ILE b 37ALA B 906 | 1.30A | 5.62 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2C12_F_SPMF1433_1 (NITROALKANE OXIDASE) | Spermine | 5 / 11 | LEU B 948VAL b 13ALA C 940LEU C 941LEU B 944 | 1.74A | 14.99 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DQY_A_BEZA401_0 (THIOREDOXIN) | Benzoic Acid | 4 / 8 | ILE c 37PHE C 909GLN C 908SER b 35 | 1.38A | 18.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BZO_C_FI8C1201_2 (DNA-DIRECTED RNAPOLYMERASE SUBUNITBETARNA POLYMERASE SIGMAFACTOR SIGA) | Fidaxomicin | 4 / 4 | LEU b 39ASP b 38GLN C 904VAL B 893 | 1.38A | 6.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AYB_A_KKKA508_1 (CYP51, STEROL14ALPHA-DEMETHYLASE) | Ketoconazole | 5 / 12 | PHE B 952ALA A 938LEU C 941ILE b 11LEU B 944 | 1.36A | 10.66 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PXM_A_ESTA2000_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 12 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.56A | 11.37 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DXE_B_ESTB1000_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 10 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.51A | 11.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DAJ_B_0HKB2000_2 (MUSCARINICACETYLCHOLINERECEPTOR M3,LYSOZYME) | Tiotropium | 3 / 3 | ASN B 907LEU a 39PHE B 909 | 0.91A | 11.92 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HJI_A_ADNA401_1 (TRNA(GUANINE(37)-N1)-METHYLTRANSFERASE TRM5A) | Adenosine | 5 / 11 | LEU b 32TYR b 36PHE C 909ILE B 913ASN B 910 | 1.70A | 7.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXE_A_1FLA2002_1 (SERUM ALBUMIN) | Diflunisal | 5 / 10 | ALA A 926LEU A 927ALA B 926SER C 919LEU C 920 | 1.51A | 9.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CFQ_B_DIFB1_1 (TRANSTHYRETIN) | Diclofenac | 5 / 7 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.79A | 22.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XDK_B_9CRB600_1 (RETINOIC ACIDRECEPTOR, BETA) | Alitretinoin | 6 / 12 | LEU B 944LEU B 948ILE b 11SER b 7LEU C 941LEU A 948 | 1.64A | 14.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MVM_A_PFLA511_1 (PROTON-GATED IONCHANNEL) | Propofol | 5 / 8 | ILE B 913ALA B 912ILE A 913ALA A 912ILE A 916 | 1.48A | 14.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P65_A_IPHA101_0 (INSULIN) | Phenol | 5 / 10 | LEU A 930LEU A 927ALA A 926LEU c 25LEU c 18 | 1.69A | 15.9118.46 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DZK_1_BEZ1801_0 (ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 1ATP-DEPENDENT CLPPROTEASE PROTEOLYTICSUBUNIT 2BEZ-LEU-LEU) | Benzoic Acid | 3 / 3 | LEU A 959PHE A 952ILE B 955 | 1.25A | 6.6716.5117.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BOJ_A_4TXA201_1 (TRANSTHYRETIN) | Gemfibrozil | 4 / 6 | LEU b 25LEU B 920SER B 919THR A 923 | 1.29A | 22.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PEO_F_CU9F301_2 (SOLUBLEACETYLCHOLINERECEPTOR) | Metocurine | 4 / 6 | GLN C 917TYR c 36GLN A 904ILE c 37 | 1.69A | 16.97 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TZ8_B_DESB128_1 (TRANSTHYRETIN) | Diethylstilbestrol | 6 / 11 | LEU a 25LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.73A | 22.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZN7_A_DESA601_1 (ESTROGEN RECEPTOR) | Diethylstilbestrol | 5 / 12 | LEU B 927ALA B 926LEU a 25LEU B 920LEU a 18 | 1.47A | 15.81 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CDU_G_EY4G502_0 (CHIMERIC ALPHA1GABAARECEPTOR) | Alfaxalone | 4 / 8 | ILE b 37GLN C 908ILE A 905TYR c 36 | 1.25A | 8.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_B_29SB601_1 (ESTROGEN RECEPTOR) | Bazedoxifene | 5 / 12 | THR A 923ALA A 926LEU C 930LEU c 18LEU c 25 | 1.34A | 15.10 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IE4_B_T44B328_1 (TRANSTHYRETIN) | Levothyroxine | 4 / 8 | GLU c 19LEU c 25ALA A 926THR A 922 | 1.22A | 19.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVW_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 10 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.69A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MUO_D_PFLD402_1 (PROTON-GATED IONCHANNEL) | Propofol | 5 / 9 | THR C 923THR B 923SER B 919ILE B 916THR A 922 | 1.50A | 14.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QYN_B_RTLB201_0 (RETINOL-BINDINGPROTEIN 2) | Vitamin A | 5 / 12 | ILE C 916THR A 923LEU C 920LEU B 927LEU b 25 | 1.24A | 23.02 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WKQ_A_IREA1101_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | Gefitinib | 5 / 12 | LEU C 920LEU c 18GLY A 928LEU A 927THR B 923 | 1.37A | 14.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G9I_B_CXXB707_1 (ENVELOPEGLYCOPROTEIN,ENVELOPE GLYCOPROTEIN) | Clomipramine | 5 / 7 | LEU C 941VAL A 945LEU A 944LEU C 948LEU A 941 | 1.43A | 13.5118.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1V55_C_CHDC3271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDE IIICYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEART) | Cholic Acid | 4 / 7 | LYS A 946LEU A 948PHE A 952LEU B 948 | 1.33A | 18.2220.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DH6_A_017A104_0 (PROTEASE) | Darunavir | 5 / 12 | LEU B 966VAL B 958ILE B 955VAL A 958ILE B 962 | 1.27A | 18.28 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VRM_A_VD3A502_1 (VITAMIN D(3)25-HYDROXYLASE) | Cholecalciferol | 5 / 12 | ILE A 916LEU b 25LEU A 920ILE C 913LEU b 32 | 1.40A | 11.76 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HV1_A_RFPA902_2 (PHOSPHOENOLPYRUVATESYNTHASE) | Rifampicin | 3 / 3 | ILE A 916THR C 923ILE B 916 | 0.69A | 7.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XN3_A_ID8A1356_1 (THYROXINE-BINDINGGLOBULIN) | Mefenamic acid | 4 / 8 | LEU A 927LEU C 930LYS C 929LEU c 18 | 1.37A | 14.0226.56 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3D90_A_NOGA1001_1 (PROGESTERONERECEPTOR) | Levonorgestrel | 5 / 12 | LEU c 16LEU C 930LEU b 16GLN B 931LEU A 927 | 1.61A | 12.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DHF_B_FOLB187_0 (DIHYDROFOLATEREDUCTASE) | Folic Acid | 5 / 12 | ILE B 916ALA a 28GLN A 915THR B 923LEU C 920 | 1.43A | 17.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2UZ2_A_ACTA1123_0 (XENAVIDIN) | Acetic acid | 4 / 7 | ASN A 935LEU a 16THR a 14VAL B 933 | 1.17A | 21.80 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B0C_D_TA1D502_1 (TUBULIN BETA CHAIN) | Paclitaxel | 6 / 12 | LEU B 930LEU C 930ALA A 926LEU B 927THR B 925LEU a 25 | 1.73A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQN_A_NDRA1001_0 (PROGESTERONERECEPTOR) | Norethisterone | 5 / 12 | LEU c 16LEU C 930LEU b 16GLN B 931LEU A 927 | 1.64A | 12.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IK6_B_HCZB262_1 (GLUTAMATE RECEPTOR 2) | Hydrochlorothiazide | 5 / 10 | ILE B 955SER B 949GLY B 953SER b 7LEU B 959 | 1.44A | 15.12 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GWS_X_T3X500_1 (THYROID HORMONERECEPTOR BETA) | Liothyronine | 5 / 12 | ILE A 913ILE A 916ALA A 912ALA C 912LEU B 920 | 1.46A | 16.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OAX_F_SNLF6001_1 (MINERALOCORTICOIDRECEPTOR) | Spironolactone | 5 / 12 | LEU B 927ALA B 926LEU B 920LEU A 920THR A 925 | 1.56A | 16.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MWY_A_YNUA1101_0 (MINERALOCORTICOIDRECEPTOR) | Eplerenone | 5 / 12 | LEU C 930LEU C 927SER C 919LEU C 920LEU b 25 | 1.36A | 16.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L9Q_B_9TPB601_1 (SERUM ALBUMIN) | Teniposide | 5 / 12 | LEU a 25ALA c 28LEU C 927GLY B 928LYS B 929 | 1.25A | 5.68 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3R9V_B_DXCB1_0 (INVASIN IPAD) | Deoxycholic Acid | 4 / 7 | LEU C 920SER B 919LEU A 920SER a 35 | 1.14A | 14.54 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GWX_A_EPAA1_2 (PROTEIN (PEROXISOMEPROLIFERATORACTIVATED RECEPTOR(PPAR-DELTA))) | Icosapent | 5 / 12 | THR B 922THR B 923ILE C 916ILE A 916LEU b 25 | 1.40A | 19.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XF1_B_ACTB1108_0 (C5A PEPTIDASE) | Acetic acid | 4 / 6 | LEU a 39ASN A 907ILE A 905PHE A 909 | 1.43A | 5.04 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1I_B_LOCB502_2 (TUBULIN BETA CHAIN) | Colchicine | 5 / 12 | LEU A 927ALA B 926LYS B 929LEU B 927ALA A 926 | 1.55A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5OG9_B_TESB503_1 (-) | Testosterone | 5 / 8 | ILE B 913LEU b 32THR A 923LEU B 920THR B 923 | 1.46A | 13.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6G31_G_ZOLG401_0 (GERANYLGERANYLPYROPHOSPHATESYNTHASE) | Zoledronic acid | 4 / 7 | GLN B 915LYS B 911GLN B 908TYR a 36 | 1.71A | 16.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O1Z_B_MXMB807_1 (PROSTAGLANDIN G/HSYNTHASE 1) | Meloxicam | 6 / 12 | VAL B 945LEU B 944VAL C 945LEU C 948ALA C 940LEU B 941 | 1.77A | 8.69 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4G24_A_ACAA1004_1 (PENTATRICOPEPTIDEREPEAT-CONTAININGPROTEIN AT2G32230,MITOCHONDRIAL) | Aminocaproic Acid | 4 / 6 | ASN C 901LEU C 898VAL C 897GLU b 41 | 1.15A | 9.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WGD_B_ESTB601_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 11 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.51A | 11.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C9N_A_CAMA1419_0 (CYTOCHROME P450) | Camphor | 4 / 8 | LEU c 18LEU C 927GLY C 928VAL B 934 | 1.25A | 9.73 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LM8_C_VIBC223_1 (THIAMINEPYROPHOSPHOKINASE) | Thiamine | 4 / 8 | LEU C 948LEU A 944SER A 950ASN A 951 | 1.10A | 14.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TBG_A_RTZA2_1 (CYTOCHROME P450 2D6) | Thioridazine | 5 / 11 | THR B 923LEU C 927SER A 919LEU b 25THR C 921 | 1.53A | 10.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LMN_A_EUIA503_1 (DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1) | Cobimetinib | 5 / 12 | LEU B 920LEU b 32ILE B 916SER C 919LEU C 920 | 1.46A | 14.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ITO_A_IREA2020_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | Gefitinib | 5 / 12 | LEU B 927SER B 924ALA C 926GLU C 918THR C 925 | 1.49A | 14.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MX1_D_THAD4_1 (LIVERCARBOXYLESTERASE I) | Tacrine | 5 / 12 | LEU A 941LEU C 948LEU A 944ILE b 11LEU b 8 | 1.20A | 11.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JO9_A_SORA302_0 (RIBITOL2-DEHYDROGENASE) | Sorbitol | 5 / 12 | LEU B 927THR C 922GLU b 21GLY B 928LEU b 25 | 1.78A | 16.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FW3_A_ETSA302_1 (CARBONIC ANHYDRASE 4) | Dorzolamide | 5 / 12 | GLN A 915ILE c 29LEU c 25THR A 923THR A 922 | 1.58A | 15.54 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BX4_A_ADNA350_2 (PROTEIN (ADENOSINEKINASE)) | Adenosine | 3 / 3 | LEU b 32SER B 914ASN B 910 | 1.24A | 9.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AXA_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) | Adenosine | 4 / 5 | GLU a 21THR B 925THR C 923LEU A 920 | 1.69A | 10.14 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERR_B_RALB600_1 (ESTROGEN RECEPTOR) | Raloxifene | 6 / 12 | LEU C 927LEU c 25ILE C 916LEU B 920LEU B 927LEU B 930 | 1.64A | 15.81 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A97_A_ZPCA1318_2 (CYS-LOOPLIGAND-GATED IONCHANNEL) | Eszopiclone | 4 / 7 | PHE b 15VAL b 13ILE b 11ASN b 12 | 1.29A | 9.60 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDING GLOBULIN) | Hydrocortisone | 5 / 12 | SER B 949VAL B 945GLN C 936THR b 14ILE b 11 | 1.59A | 13.51 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVN_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 11 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.66A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L1W_A_STRA402_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C2) | Progesterone | 4 / 7 | VAL a 13ILE a 11LEU C 948LEU A 948 | 1.25A | 9.84 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HS1_A_VORA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) | Voriconazole | 5 / 8 | PHE B 909ILE B 913PHE C 909LEU c 32LEU C 920 | 1.75A | 10.85 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OAX_A_SNLA1001_1 (MINERALOCORTICOIDRECEPTOR) | Spironolactone | 5 / 12 | LEU c 16LEU b 16GLN B 931LEU B 927LEU a 18 | 1.36A | 12.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FIA_A_198A602_1 (CHOLESTEROL24-HYDROXYLASE) | Bicalutamide | 5 / 12 | LEU C 930ALA B 926THR B 923ALA C 926THR C 923 | 1.33A | 12.41 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6F88_B_STRB502_1 (CYTOCHROME P450CYP260A1) | Progesterone | 4 / 6 | LEU B 941ALA C 940LEU A 944ASN c 12 | 1.41A | 12.00 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1I_D_LOCD502_1 (TUBULIN BETA CHAIN) | Colchicine | 5 / 12 | LEU A 920LEU C 920ALA A 912ALA c 28ILE A 913 | 1.13A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3H5G_A_LEIA16_0 (COIL SER L16D-PEN) | Penicillamine | 4 / 6 | LYS A 929GLN A 931LEU A 930LEU B 930 | 1.74A | 17.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) | Ponatinib | 5 / 12 | LEU c 25LEU C 927THR A 923LEU C 930ALA C 926 | 1.39A | 11.03 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y80_A_IREA401_0 (CYCLIN-G-ASSOCIATEDKINASE) | Gefitinib | 5 / 12 | LEU A 930ALA A 926THR A 923LEU c 18GLY C 928 | 1.37A | 15.44 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W9S_E_TOPE1160_1 (DIHYDROFOLATEREDUCTASE TYPE 1FROM TN4003) | Trimethoprim | 4 / 8 | ILE b 37ALA C 906LEU c 39ILE B 905 | 1.03A | 18.42 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XOT_A_VDNA101_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4B) | Vardenafil | 5 / 12 | LEU a 25ILE B 916SER a 35GLN B 915ILE a 29 | 1.68A | 7.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4K4Y_A_ACTA502_0 (RNA-DEPENDENT RNAPOLYMERASE) | Acetic acid | 4 / 5 | LYS A 929LEU A 930GLU c 21LEU C 927 | 1.22A | 12.39 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR) | Estriol | 5 / 12 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.52A | 11.51 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M7R_A_VDXA425_1 (VITAMIN D3 RECEPTOR) | Calcitriol | 5 / 12 | LEU c 25LEU C 920SER C 919SER B 919LEU C 930 | 1.55A | 13.31 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CD2_A_MTXA307_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | ILE C 916ILE A 913SER A 914LEU A 920ILE B 916 | 1.62A | 19.76 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ERE_E_ESTE600_1 (ESTROGEN RECEPTOR) | Estradiol | 4 / 8 | ALA A 926GLU c 21LEU c 18LEU B 930 | 1.19A | 15.81 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FIA_A_198A602_1 (CHOLESTEROL24-HYDROXYLASE) | Bicalutamide | 5 / 12 | LEU c 25ALA A 926THR A 925GLU A 918THR A 921 | 1.56A | 8.44 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z90_F_4LEF402_1 (GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNITBETA-1) | Isoflurane | 5 / 7 | LEU A 930LEU C 930ALA C 926LEU A 927ALA A 926 | 1.33A | 13.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1CQP_A_803A311_1 (ANTIGEN CD11A (P180)) | Lovastatin | 5 / 10 | LEU A 959VAL A 958ILE A 962LEU B 966VAL C 958 | 1.33A | 19.57 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A7A_B_RGZB601_1 (AMINE OXIDASE[FLAVIN-CONTAINING]B) | Rosiglitazone | 6 / 12 | LEU C 941LEU C 944LEU C 948ILE c 11GLN A 947PHE C 952 | 1.57A | 11.54 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1K_B_LOCB502_1 (TUBULIN ALPHA CHAINTUBULIN BETA CHAIN) | Colchicine | 5 / 12 | VAL B 934ALA B 926LYS B 929LEU B 927ALA A 926 | 1.57A | 11.7012.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VW1_B_CVIB301_0 (PUTATIVE REGULATORYPROTEIN) | Gentian Violet | 5 / 12 | THR C 921ALA a 28LEU b 25LEU A 920LEU c 32 | 1.26A | 16.92 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XN6_A_T44A1370_1 (THYROXINE-BINDINGGLOBULIN) | Levothyroxine | 5 / 10 | ALA B 926LEU c 16LEU c 18LEU A 927LEU A 930 | 1.37A | 14.0226.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3H5G_B_LEIB16_0 (COIL SER L16D-PEN) | Penicillamine | 4 / 5 | LEU B 930LYS C 929GLN C 931LEU b 16 | 1.70A | 17.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PGF_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) | Adenosine | 4 / 6 | THR A 922GLU c 21THR A 923THR C 921 | 1.26A | 10.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MRQ_A_STRA501_1 (ALDO-KETO REDUCTASEFAMILY 1 MEMBER C1) | Progesterone | 5 / 11 | LEU A 941VAL a 13ILE a 11LEU C 948LEU A 948 | 1.23A | 14.06 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TQ9_A_MTXA2001_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | ILE A 913LEU b 32SER C 919LEU A 920ILE A 916 | 1.28A | 20.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ND7_B_TA1B601_1 (TUBULIN BETA-2BCHAIN) | Paclitaxel | 5 / 12 | VAL B 934ASP B 932LEU c 18LEU c 16LEU a 18 | 1.17A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IIZ_A_LURA201_1 (TRANSTHYRETIN) | Lumiracoxib | 3 / 3 | LYS C 903LEU c 39ALA C 906 | 1.25A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | Acarbose | 5 / 10 | THR A 943PHE a 15ASN a 12ALA A 938GLN A 939 | 1.69A | 6.86 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DG5_A_TOPA201_1 (DIHYDROFOLATEREDUCTASE) | Trimethoprim | 5 / 11 | ILE A 913ALA A 912ILE C 913PHE A 909SER b 35 | 1.51A | 21.48 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EUP_A_ASDA452_1 (CYTOCHROME P450ERYF) | 4-Androstenedione | 5 / 8 | PHE C 952SER A 956ILE A 955LEU A 959LEU B 959 | 1.18A | 12.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AZX_A_TRPA602_0 (TRYPTOPHANYL-TRNASYNTHETASE) | L-Tryptophan | 4 / 8 | LEU A 959ILE A 955LEU B 959ILE B 962 | 1.23A | 10.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AO8_A_MTXA170_1 (DIHYDROFOLATEREDUCTASE) | Methotrexate | 5 / 12 | LEU B 930ALA C 926THR B 922SER B 919ALA B 926 | 1.49A | 18.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UUN_A_ACTA307_0 (GLUTATHIONES-TRANSFERASE-LIKEPROTEIN) | Acetic acid | 4 / 4 | LEU b 25LEU B 927SER C 924ALA C 926 | 1.65A | 10.92 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ROX_B_T44B128_1 (TRANSTHYRETIN) | Levothyroxine | 4 / 6 | LEU C 930GLU b 21LEU A 930THR A 923 | 1.43A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Q0D_A_MTXA604_1 (BIFUNCTIONALDIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) | Methotrexate | 5 / 12 | VAL c 13LEU B 944LEU C 948ILE b 11THR A 943 | 1.53A | 7.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZN7_A_DESA601_1 (ESTROGEN RECEPTOR) | Diethylstilbestrol | 6 / 12 | MET c 22LEU C 927ALA C 926LEU b 16LEU b 18LEU B 930 | 1.74A | 11.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KUO_A_RBFA500_1 (BLUE-LIGHTPHOTORECEPTOR) | Riboflavin | 5 / 12 | SER C 949ASN A 951LEU A 944ASN B 951LEU B 948 | 1.39A | 19.18 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I41_A_MIXA500_2 (SERINE/THREONINE-PROTEIN KINASE PIM-1) | Mitoxantrone | 4 / 4 | LEU c 39LEU C 898GLN A 908GLU A 900 | 1.55A | 17.10 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_B_8LXB501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | Lobeglitazone | 5 / 12 | PHE A 909ILE C 913ILE b 29LEU B 920ILE A 916 | 1.63A | 14.29 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z91_F_4LEF401_1 (GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNITBETA-1) | Isoflurane | 5 / 7 | LEU A 920THR A 922THR C 923LEU C 920THR B 923 | 1.37A | 13.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NKX_A_STRA601_1 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) | Progesterone | 6 / 12 | ALA B 912PHE B 909ILE A 905ILE c 37ALA A 912ILE B 913 | 1.65A | 12.01 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R3A_A_RBFA402_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) | Riboflavin | 5 / 12 | ALA b 28ALA B 912ILE B 916LEU c 32GLN C 917 | 1.55A | 11.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WEK_A_DIFA1373_1 (ZINC-BINDING ALCOHOLDEHYDROGENASEDOMAIN-CONTAININGPROTEIN 2) | Diclofenac | 4 / 8 | ASN B 935PHE b 15VAL C 933ASN b 12 | 1.26A | 12.72 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BOJ_B_4TXB201_1 (TRANSTHYRETIN) | Gemfibrozil | 5 / 7 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.75A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P65_E_IPHE101_0 (INSULIN) | Phenol | 5 / 11 | ILE b 11LEU B 948LEU B 944LEU C 941LEU C 948 | 1.41A | 17.9526.67 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XN7_A_T44A1355_1 (THYROXINE-BINDINGGLOBULIN) | Levothyroxine | 5 / 10 | ALA B 926LEU c 16LEU c 18LEU A 927LEU A 930 | 1.44A | 14.0226.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PBK_A_RAPA225_1 (FKBP25) | Sirolimus | 5 / 12 | LEU C 920LYS c 31ILE C 913ALA B 912ILE B 913 | 1.51A | 24.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W9H_A_TOPA1160_1 (DIHYDROFOLATEREDUCTASE) | Trimethoprim | 5 / 10 | LEU c 25ALA C 926LEU B 927LEU b 25THR C 925 | 1.45A | 13.16 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V04_A_0LIA1772_1 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) | Ponatinib | 5 / 12 | ALA C 938VAL C 934LEU a 18ASP A 932GLY A 928 | 1.28A | 14.86 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OAX_E_SNLE5001_1 (MINERALOCORTICOIDRECEPTOR) | Spironolactone | 5 / 12 | LEU c 16LEU b 16GLN B 931LEU B 927LEU a 18 | 1.23A | 12.15 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WEA_A_IPHA901_0 (PROTEIN ARGONAUTE-2) | Phenol | 4 / 5 | LEU B 930LYS B 929LEU a 18GLU a 21 | 1.67A | 8.42 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WQ4_A_ACTA403_0 (TRNA N6-ADENOSINETHREONYLCARBAMOYLTRANSFERASE) | Acetic acid | 3 / 3 | VAL A 934LEU a 16VAL B 933 | 0.90A | 13.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z91_A_4LEA401_1 (GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNITBETA-1) | Isoflurane | 6 / 8 | LEU A 927ALA A 926LEU A 930LEU C 930ALA C 926LEU B 927 | 1.41A | 13.64 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1G_B_LNLB701_1 (PROSTAGLANDIN G/HSYNTHASE 2) | Alpha-Linolenic Acid | 5 / 12 | PHE A 952GLY A 953ALA A 954SER A 956LEU A 959 | 1.58A | 8.24 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BOJ_A_4TXA201_1 (TRANSTHYRETIN) | Gemfibrozil | 5 / 6 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.75A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ICT_C_T44C128_1 (TRANSTHYRETIN) | Levothyroxine | 5 / 11 | LEU b 25LEU a 25GLU a 21LEU A 920THR C 923 | 1.42A | 22.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) | Ponatinib | 5 / 12 | ALA A 926LEU b 18LEU B 930LEU a 18ALA B 926 | 1.37A | 13.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1A28_A_STRA1_1 (PROGESTERONERECEPTOR) | Progesterone | 5 / 12 | LEU A 920LEU a 32GLN B 915LEU A 927THR C 923 | 1.67A | 19.44 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EM0_B_CHDB500_0 (ILEAL BILEACID-BINDING PROTEIN) | Cholic Acid | 4 / 7 | LYS b 24THR C 922GLU C 918THR C 921 | 1.39A | 15.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V04_B_0LIB1771_2 (FIBROBLAST GROWTHFACTOR RECEPTOR 1(FMS-RELATEDTYROSINE KINASE 2,PFEIFFER SYNDROME),ISOFORM CRA_B) | Ponatinib | 5 / 12 | ALA C 938VAL C 934LEU a 18ASP A 932GLY A 928 | 1.29A | 14.86 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HI2_A_BAXA801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) | Sorafenib | 5 / 12 | GLU a 21LEU A 927LEU B 930LEU b 25GLY B 928 | 1.69A | 10.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Y0R_A_PX9A201_0 (BETA-LACTOGLOBULIN) | Pramocaine | 5 / 12 | LEU B 898LEU C 898LEU a 39ILE B 905ILE C 905 | 1.21A | 20.38 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EIJ_C_CHDC271_0 (CYTOCHROME C OXIDASEPOLYPEPTIDEVIIA-HEARTCYTOCHROME C OXIDASESUBUNIT 3) | Cholic Acid | 4 / 7 | LYS A 946LEU A 948PHE A 952LEU B 948 | 1.31A | 18.2220.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QW3_V_BO2V301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 11 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.69A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6D8P_A_ACTA814_0 (UNCHARACTERIZEDPROTEIN) | Acetic acid | 4 / 5 | GLN B 936ASN B 937THR a 14LEU a 16 | 1.33A | 8.30 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P7L_C_SAMC685_1 (S-ADENOSYLMETHIONINESYNTHETASE) | S-Adenosylmethionine | 4 / 8 | ALA A 906GLN A 908ASP c 38ILE c 37 | 1.14A | 12.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VCY_A_DB8A401_1 (MEMBRANE-ASSOCIATEDTYROSINE- ANDTHREONINE-SPECIFICCDC2-INHIBITORYKINASE) | Bosutinib | 5 / 12 | LEU B 930ALA B 926LEU b 25THR B 923GLY A 928 | 1.16A | 14.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VEU_A_RITA602_1 (CYTOCHROME P450 3A5) | Ritonavir | 5 / 12 | SER A 956PHE B 952PHE C 952ILE B 955ALA B 954 | 1.39A | 11.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3I45_A_NIOA500_1 (TWIN-ARGININETRANSLOCATIONPATHWAY SIGNALPROTEIN) | Niacin | 4 / 8 | PHE C 952SER C 949PHE B 952LEU B 948 | 1.38A | 12.08 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TOA_A_ESTA601_1 (ESTROGEN RECEPTORBETA) | Estradiol | 5 / 12 | LEU B 927ALA B 926LEU A 927LEU c 16LEU a 16 | 1.12A | 20.11 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QD3_A_CHDA501_0 (FERROCHELATASE) | Cholic Acid | 5 / 11 | LEU b 8LEU C 948LEU c 8ILE b 11THR A 943 | 1.60A | 10.03 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GP0_A_NILA1_1 (MITOGEN-ACTIVATEDPROTEIN KINASE 11) | Nilotinib | 5 / 12 | ALA B 912LEU b 25LEU B 920ILE C 916ALA A 912 | 1.41A | 13.19 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R38_A_RBFA201_1 (BLUE-LIGHT-ACTIVATEDHISTIDINE KINASE 2) | Riboflavin | 5 / 12 | ALA b 28ALA B 912ILE B 916LEU c 32GLN C 917 | 1.57A | 20.37 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HYR_A_ESTA601_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 10 | MET a 22LEU A 927ALA A 926LEU c 18LEU C 930 | 1.53A | 11.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CEO_A_T44A1395_1 (THYROXINE-BINDINGGLOBULIN) | Levothyroxine | 5 / 11 | LEU b 16LEU C 930SER B 924LEU B 927LEU b 18 | 1.26A | 9.43 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3W67_A_VIVA301_0 (ALPHA-TOCOPHEROLTRANSFER PROTEIN) | Vitamin E | 5 / 11 | LEU b 8ILE c 11VAL B 945LEU B 941VAL b 13 | 1.48A | 9.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3D90_B_NOGB2001_1 (PROGESTERONERECEPTOR) | Levonorgestrel | 5 / 12 | LEU a 16LEU A 930LEU c 16GLN C 931LEU C 927 | 1.47A | 12.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BZF_A_TMQA170_1 (DIHYDROFOLATEREDUCTASE) | Trimetrexate | 5 / 12 | LEU c 18LEU a 18LEU a 16THR B 923LEU b 18 | 1.52A | 9.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1K_B_LOCB502_1 (TUBULIN ALPHA CHAINTUBULIN BETA CHAIN) | Colchicine | 5 / 12 | LEU c 18LEU C 930LEU A 927THR B 922ALA C 926 | 1.51A | 6.618.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MSS_D_STID1_1 (TYROSINE-PROTEINKINASE ABL1) | Imatinib | 5 / 12 | LEU A 930ALA A 926ILE C 916THR A 923GLY C 928 | 1.31A | 14.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IKR_B_ID8B602_2 (PROSTAGLANDIN G/HSYNTHASE 2) | Mefenamic acid | 3 / 3 | SER B 919LEU b 18MET b 22 | 1.25A | 9.51 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WY0_A_SAMA800_0 (SMALL RNA2'-O-METHYLTRANSFERASE) | S-Adenosylmethionine | 5 / 12 | GLY B 953ASN B 951VAL B 945LEU b 8LEU C 944 | 1.44A | 20.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y2T_B_8LXB501_0 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | Lobeglitazone | 5 / 12 | LEU a 32PHE A 909ILE A 916GLN C 917ILE B 913 | 1.55A | 10.20 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DVX_B_DIFB125_2 (TRANSTHYRETIN) | Diclofenac | 5 / 7 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.65A | 23.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KP6_B_SALB3003_1 (TRANSCRIPTIONALREGULATOR TCAR) | Salicylic acid | 4 / 6 | ILE a 11VAL A 945LEU A 948LEU B 948 | 1.13A | 17.88 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XI3_C_29SC601_1 (ESTROGEN RECEPTOR) | Bazedoxifene | 5 / 12 | THR A 923ALA A 926LEU C 930LEU c 18LEU c 25 | 1.35A | 15.10 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NYR_B_SVRB401_2 (NAD-DEPENDENTDEACETYLASESIRTUIN-5) | Suramin | 4 / 6 | GLN C 947ASN C 951ASN c 12LEU C 941 | 1.42A | 15.79 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OZV_A_ECNA411_1 (FLAVOHEMOGLOBIN) | Econazole | 5 / 8 | ILE C 913GLN C 917ALA c 28LEU b 32ILE B 913 | 1.49A | 11.41 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVQ_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 11 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.66A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2CEO_A_T44A1395_1 (THYROXINE-BINDINGGLOBULIN) | Levothyroxine | 5 / 11 | LEU C 941LEU C 944SER A 949LEU A 948LEU A 944 | 1.38A | 14.16 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JQB_B_IBPB706_1 (ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN1,ENVELOPEGLYCOPROTEIN 1ENVELOPEGLYCOPROTEIN 2) | Ibuprofen | 5 / 8 | ALA B 940LEU A 948LEU B 948LEU C 941LEU A 944 | 1.49A | 13.8418.71 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RG9_A_SAMA385_1 (S-ADENOSYLMETHIONINESYNTHETASE) | S-Adenosylmethionine | 4 / 8 | ALA A 906GLN A 908ASP c 38ILE c 37 | 1.11A | 12.95 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZBP_A_SAMA300_0 (RIBOSOMAL PROTEINL11METHYLTRANSFERASE) | S-Adenosylmethionine | 6 / 12 | PHE c 15LEU B 941ILE b 11ASN A 937LEU C 941LEU A 944 | 1.79A | 12.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6FBV_D_FI8D1904_0 (DNA-DIRECTED RNAPOLYMERASE SUBUNITBETADNA-DIRECTED RNAPOLYMERASE SUBUNITBETA') | Fidaxomicin | 4 / 8 | ILE b 37GLN B 902VAL B 897GLU B 900 | 1.40A | 3.75 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QW0_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 11 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.64A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HWI_B_115B1_1 (HMG-COA REDUCTASE) | Fluvastatin | 5 / 9 | ASN A 935LEU a 18ALA B 926LEU A 927LEU B 927 | 1.68A | 11.23 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5U4S_B_BEZB301_0 (PUTATIVE SHORT CHAINDEHYDROGENASE) | Benzoic Acid | 4 / 8 | SER C 919ILE C 916LEU B 920LEU b 25 | 1.46A | 14.78 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WG0_A_CHDA103_0 (NUCLEAR RECEPTORCOACTIVATOR 2) | Cholic Acid | 4 / 8 | LEU A 944LEU A 948ALA B 940LEU B 944 | 1.10A | 12.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KC0_A_RBFA303_2 (RIBOFLAVINTRANSPORTER RIBU) | Riboflavin | 3 / 3 | LYS C 911LEU c 32ILE B 916 | 1.02A | 19.77 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QHS_A_CLMA999_0 (PROTEIN(CHLORAMPHENICOLPHOSPHOTRANSFERASE)) | Chloramphenicol | 5 / 12 | ILE B 913ILE B 916ILE A 916LEU c 32GLN C 917 | 1.39A | 21.17 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QJU_A_DSMA801_1 (TRANSPORTER) | Desipramine | 5 / 11 | LEU b 32ILE B 916PHE B 909ALA A 912LEU a 32 | 1.44A | 5.68 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVV_H_BO2H301_1 (PROTEASOME SUBUNITBETA TYPE-2) | Bortezomib | 5 / 11 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.59A | 18.53 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QT0_A_486A4_2 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) | Mifepristone | 4 / 4 | LYS b 40GLN C 908ILE A 905LEU A 898 | 1.09A | 17.65 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RP8_C_ASCC501_0 (ASCORBATE-SPECIFICPERMEASE IICCOMPONENT ULAA) | Vitamin C | 5 / 12 | LEU A 920ILE B 916ILE a 29ALA a 28ILE A 913 | 1.58A | 10.35 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DHF_A_FOLA187_0 (DIHYDROFOLATEREDUCTASE) | Folic Acid | 5 / 12 | ILE C 955ALA C 954PHE C 952GLN A 947LEU A 948 | 1.51A | 17.22 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1IG3_A_VIBA502_1 (THIAMINPYROPHOSPHOKINASE) | Thiamine | 4 / 8 | LEU a 16ASN B 937GLN B 939THR b 14 | 1.41A | 12.07 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4M93_B_ACTB303_0 (S25-26 FAB (IGG1K)HEAVY CHAINS25-26 FAB (IGG1K)LIGHT CHAIN) | Acetic acid | 4 / 5 | GLY B 953SER B 950ALA B 954PHE B 952 | 1.45A | 16.5918.89 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IJX_B_HCZB800_1 (GLUTAMATE RECEPTOR 2) | Hydrochlorothiazide | 5 / 10 | SER b 7LEU B 959ILE B 955SER B 949GLY B 953 | 1.42A | 10.98 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) | Tanaproget | 5 / 12 | LEU C 941ASN C 942LEU C 944LEU A 948THR c 14 | 1.57A | 19.44 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W8Y_B_NDRB1000_0 (PROGESTERONERECEPTOR) | Norethisterone | 5 / 12 | LEU c 16LEU A 930LEU a 16MET a 22LEU C 927 | 1.63A | 12.45 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4OR0_A_NPSA603_1 (SERUM ALBUMIN) | Naproxen | 5 / 11 | LEU B 930LEU c 18ASP A 932LEU a 16LEU C 930 | 1.68A | 8.47 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4WG0_B_CHDB102_0 (NUCLEAR RECEPTORCOACTIVATOR 2) | Cholic Acid | 5 / 11 | LEU A 944LEU A 948LEU C 944ALA B 940LEU B 944 | 1.14A | 12.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IEP_A_VDYA201_1 (CDL2.3B) | Calcidiol | 5 / 12 | LEU b 25LEU a 18THR A 923ALA A 926LEU c 16 | 1.47A | 17.54 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HYR_B_ESTB601_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 11 | LEU b 16LEU B 930LEU B 927MET c 22LEU c 16 | 1.69A | 11.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MKC_A_4MKA1503_1 (ALK TYROSINE KINASERECEPTOR) | Ceritinib | 5 / 12 | LEU A 920ALA a 28LYS a 24LEU a 32SER C 919 | 1.27A | 11.60 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LTW_A_STRA301_1 (ANCESTRAL STEROIDRECEPTOR 2) | Progesterone | 5 / 12 | LEU a 16LEU A 930LEU c 16GLN C 931LEU b 18 | 1.48A | 11.57 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W3M_B_FOLB1188_0 (DIHYDROFOLATEREDUCTASE) | Folic Acid | 5 / 12 | ILE C 916ALA b 28LEU b 25GLN B 915LEU A 920 | 1.52A | 17.68 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YIA_B_IMNB401_1 (THYROXINE-BINDINGGLOBULIN) | Indomethacin | 5 / 10 | LEU A 944LEU C 944SER B 950LEU B 948LEU B 941 | 1.51A | 14.25 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BAA_E_GBME2001_2 (ATP-BINDING CASSETTESUB-FAMILY C MEMBER8) | Glyburide | 3 / 3 | LEU a 18THR a 14ASN B 937 | 1.16A | 2.74 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4X1I_D_LOCD502_1 (TUBULIN BETA CHAIN) | Colchicine | 5 / 12 | LEU c 18LEU C 930LEU A 927THR B 922ALA C 926 | 1.40A | 8.33 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LIN_A_TFPA154_1 (CALMODULIN) | Trifluoperazine | 4 / 7 | LEU A 930LEU b 18GLU b 21MET b 22 | 1.62A | 23.85 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PWJ_B_30ZB201_1 (TRANSTHYRETIN) | Masoprocol | 5 / 7 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.74A | 19.23 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZUC_B_T98B202_1 (PROGESTERONERECEPTOR) | Tanaproget | 5 / 12 | LEU a 16LEU A 930LEU c 16GLN C 931LEU C 927 | 1.50A | 12.90 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4L9I_A_8PRA601_1 (RHODOPSIN KINASE) | Paroxetine | 4 / 7 | VAL C 934ALA C 938LEU B 930ASP c 17 | 1.25A | 10.87 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IAA_A_RTZA401_1 (SERINE/THREONINE-PROTEIN KINASE PIM-1) | Thioridazine | 5 / 11 | ALA C 938ASP c 17GLU c 19LEU c 16ASP C 932 | 1.45A | 12.99 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PXM_A_ESTA2000_1 (ESTROGEN RECEPTOR) | Estradiol | 5 / 12 | LEU B 927ALA B 926LEU A 927LEU C 927LEU a 16 | 1.49A | 14.50 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3P2K_B_SAMB6735_0 (16S RRNA METHYLASE) | S-Adenosylmethionine | 5 / 12 | VAL C 933ALA C 926GLU b 21LEU a 18LEU B 927 | 1.55A | 17.84 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IKK_A_SUZA201_1 (TRANSTHYRETIN) | Sulindac | 5 / 8 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.78A | 22.83 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QVL_V_BO2V301_1 (PROTEASOME SUBUNITBETA TYPE-2PROTEASOME SUBUNITBETA TYPE-3) | Bortezomib | 5 / 10 | THR C 923GLN B 931THR B 925ALA B 926THR B 922 | 1.66A | 18.5318.32 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EEY_C_SAMC300_1 (PUTATIVE RRNAMETHYLASE) | S-Adenosylmethionine | 3 / 3 | ASN C 942ASP c 9GLN c 10 | 1.47A | 16.58 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OZK_A_T44A128_1 (TRANSTHYRETIN) | Levothyroxine | 5 / 9 | LEU B 930ALA B 926LEU B 927SER B 924THR B 922 | 1.77A | 21.26 | None | ||
| Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1M17_A_AQ4A999_1 (EPIDERMAL GROWTHFACTOR RECEPTOR) | Erlotinib | 5 / 12 | LEU C 920LEU c 18GLY A 928LEU A 927THR B 923 | 1.39A | 15.26 | None |